美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

輝瑞

27.14

+0.08000.30%

盤後：27.06-0.0800-0.29%18:42 EST

成交量：3,467.34萬

成交額：9.43億

市值：1,543.10億

市盈率：19.96

高：27.42

開：27.14

低：27.08

收：27.06

52周最高：27.94

52周最低：20.92

股本：56.86億

流通股本：56.76億

量比：0.98

換手率：0.61%

股息：1.72

股息率：6.34%

每股收益(TTM):1.36

每股收益(LYR):1.36

淨資產收益率：8.58%

總資產收益率：5.19%

市淨率：1.66

市盈率(LYR):19.89

資料載入中...

總覽公司新聞資訊公告

先為達生物與輝瑞中國就GLP-1藥物達成合作；三生國健2025年度歸母淨利潤增長317.09% | 醫藥早參

每日经济新闻

美國FDA全面批准輝瑞Braftovi聯合療法用於一線治療轉移性結直腸癌

FDA正式批准Encorafenib用於治療BRAF V600E突變型轉移性結直腸癌

中國減肥藥市場增加新跨國巨頭玩家，輝瑞也要加入「價格戰」？

輝瑞與 Sciwind Biosciences 達成糖尿病藥物交易

先為達生物攜手輝瑞中國，達成埃諾格魯肽商業化戰略合作協議

BRIEF-中國先為達生物將向輝瑞收取至多4.95億美元，輝瑞獲其減肥藥在中國大陸的獨家商業化權益

杭州Sciwind生物與輝瑞中國就新一代Ecnoglutide注射劑商業化達成戰略合作協議

2025年全球暢銷藥TOP50來了

2025年藥企營收TOP10

標普500【8】為什麼「新冠剋星」，只能是輝瑞？（9）

輝瑞將從美國證券交易委員會起訴史蒂文-科恩對沖基金案中獲賠 2900 萬美元

輝瑞第四財季淨利潤達14.2億盧比

紅杉中國抄底拜覆樂，指派輝瑞金肖東復興老牌抗生素？

諾和諾德聯合減重療法臨床3期結果積極；輝瑞超長效GLP-1受體激動劑將啓動3期試驗…… | TIDES周報

專家稱，TrumpRx 在推出減肥藥之外，影響力有限

輝瑞抗感染創新藥獲批兒科適應證

FDA授予Hympavzi®（Marstacimab）優先審評資格，用於治療存在重大醫療需求的兩類血友病A或B患者羣體

輝瑞推出優惠計劃：覆蓋女性健康、偏頭痛、關節炎及罕見病等30多個品牌

減肥藥稱王！輝瑞百億美元入場要彎道超車？

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/PFE/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PFE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PFE\",,,,,undefined,":{"symbol":"PFE","market":"US","secType":"STK","nameCN":"輝瑞","latestPrice":27.14,"timestamp":1771966800000,"preClose":27.06,"halted":0,"volume":34673408,"hourTrading":{"tag":"盘后","latestPrice":27.06,"preClose":27.14,"latestTime":"18:42 EST","volume":5795602,"amount":157283446.455228,"timestamp":1771976564522,"change":-0.08,"changeRate":-0.002948,"amplitude":0.005895},"delay":0,"changeRate":0.002956393200295708,"floatShares":5675908374,"shares":5685707552,"eps":1.36,"marketStatus":"盤後交易","change":0.08,"latestTime":"02-24 18:42:46 EST","open":27.14,"high":27.42,"low":27.08,"amount":943130670.9834241,"amplitude":0.012565,"askPrice":27.06,"askSize":212,"bidPrice":27.05,"bidSize":18,"shortable":3,"etf":0,"ttmEps":1.36,"tradingStatus":3,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1771981200000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":-819144000000,"exchange":"NYSE","adjPreClose":27.06,"dividendRate":0.063412,"preHourTrading":{"tag":"盘前","latestPrice":27.16,"preClose":27.06,"latestTime":"09:29 EST","volume":56933,"amount":1542714.810459,"timestamp":1771943385523,"change":0.1,"changeRate":0.003695,"amplitude":0.006652},"postHourTrading":{"tag":"盘后","latestPrice":27.06,"preClose":27.14,"latestTime":"18:42 EST","volume":5795602,"amount":157283446.455228,"timestamp":1771976564522,"change":-0.08,"changeRate":-0.002948,"amplitude":0.005895},"volumeRatio":0.984093,"optionData":{"bulkOrders":[{"symbol":"PFE","call":false,"expireDate":1789704000000,"strike":"24.0","timestamp":1771952574027,"price":0.83,"volume":7582,"amount":629306,"type":"+"},{"symbol":"PFE","call":false,"expireDate":1773979200000,"strike":"25.0","timestamp":1771949738909,"price":0.09,"volume":4500,"amount":40500,"type":"-"}]},"impliedVol":0.266,"impliedVolPercentile":0.3267},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PFE\",,,,,undefined,":{"symbol":"PFE","floatShares":5675908374,"roa":"5.19%","roe":"8.58%","lyrEps":1.364375,"volumeRatio":0.984093,"shares":5685707552,"dividePrice":1.721,"high":27.42,"amplitude":0.012565,"preClose":27.06,"low":27.08,"week52Low":20.915,"pbRate":"1.66","psRate":"2.47","week52High":27.94,"institutionHeld":0.6484,"latestPrice":27.14,"committee":-0.843478,"eps":1.36,"divideRate":0.063412,"volume":34673408,"delay":0,"ttmEps":1.36,"open":27.14,"prevYearClose":24.9,"prevWeekClose":26.65,"prevMonthClose":26.44,"prevQuarterClose":24.9,"fiveDayClose":27.37,"twentyDayClose":25.88,"sixtyDayClose":25.72,"dividendPayoutRate":1.2578515164789519,"dividendFrequency":"Q","dividendGrowthYears":10,"dividendGrowthRate":0.023809523809523697,"fiveYearAvgDividendRate":0.04946357584579563},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PFE\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-02-03","symbol":"PFE","fiscalQuarterEnding":"2025/12","expectedEps":0.57,"name":null,"time":"盤前","type":"earning","dateTimestamp":1770094800000,"reportTimeType":"pre","actualEps":0.66},{"date":"2026-01-23","symbol":"PFE","amount":0.43,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-01-23","defaultRemindTime":1769178600000,"name":"辉瑞","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-06","payableDate":"2026-01-23","currency":"USD","dateTimestamp":1769144400000,"payDate":"2026-03-06"},{"date":"2025-11-07","symbol":"PFE","amount":0.43,"announcedDate":"2025-10-09","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-11-07","defaultRemindTime":1762525800000,"name":"辉瑞","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-01","payableDate":"2025-11-07","currency":"USD","dateTimestamp":1762491600000,"payDate":"2025-12-01"},{"market":"US","date":"2025-11-04","symbol":"PFE","fiscalQuarterEnding":"2025/09","expectedEps":0.66,"name":null,"time":"盤前","type":"earning","dateTimestamp":1762232400000,"reportTimeType":"pre","actualEps":0.87},{"market":"US","date":"2025-08-05","symbol":"PFE","fiscalQuarterEnding":"2025/06","expectedEps":0.58,"name":null,"time":"盤前","type":"earning","dateTimestamp":1754366400000,"reportTimeType":"pre","actualEps":0.78}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PFE\",market:\"US\",,,undefined,":[{"executeDate":"2016-05-11","recordDate":"2016-05-13","paymentDate":"2016-06-01","value":0.3,"currency":"USD"},{"executeDate":"2016-08-03","recordDate":"2016-08-05","paymentDate":"2016-09-01","value":0.3,"currency":"USD"},{"executeDate":"2016-11-08","recordDate":"2016-11-11","paymentDate":"2016-12-01","value":0.3,"currency":"USD"},{"executeDate":"2017-05-10","recordDate":"2017-05-12","paymentDate":"2017-06-01","value":0.32,"currency":"USD"},{"executeDate":"2017-08-02","recordDate":"2017-08-04","paymentDate":"2017-09-01","value":0.32,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PFE\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1333,"buy":0.2333,"hold":0.5667,"sell":0.0333,"strongSell":0.0333,"meanLabel":"HOLD","meanPercent":0.5667,"analysts":30,"updateTime":1771736400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PFE\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PFE","date":"2026-02-23","current":20.0625,"percent":0.774116,"low":-564.275286,"twenty":8.045367,"median":14.235961,"eighty":20.399112,"high":75.601276,"avg":-11.338759,"sd":116.551992,"marketCap":151524106260},"quantilePoints":[{"date":"2021-02-26","current":20.394673,"twenty":11.412076,"median":19.846528,"eighty":24.37168,"marketCap":186794811653},{"date":"2021-03-05","current":20.942753,"twenty":11.409861,"median":19.979527,"eighty":24.37434,"marketCap":191814678195},{"date":"2021-03-12","current":21.279731,"twenty":11.409861,"median":20.149239,"eighty":24.37434,"marketCap":194901052046},{"date":"2021-03-19","current":21.639062,"twenty":11.409861,"median":20.299846,"eighty":24.37434,"marketCap":198192168838},{"date":"2021-03-26","current":22.077568,"twenty":11.412076,"median":20.33376,"eighty":24.37168,"marketCap":202208446957},{"date":"2021-04-01","current":22.10802,"twenty":11.412076,"median":20.387438,"eighty":24.37168,"marketCap":202487355160},{"date":"2021-04-09","current":22.290731,"twenty":11.409861,"median":20.482136,"eighty":24.37434,"marketCap":204160804376},{"date":"2021-04-16","current":23.490533,"twenty":11.409861,"median":20.580846,"eighty":24.37434,"marketCap":215149787562},{"date":"2021-04-23","current":23.545346,"twenty":11.409861,"median":20.672898,"eighty":24.37434,"marketCap":215651822327},{"date":"2021-04-30","current":23.539255,"twenty":11.409861,"median":20.714304,"eighty":24.37434,"marketCap":215596040687},{"date":"2021-05-07","current":20.670699,"twenty":11.409861,"median":20.745571,"eighty":24.37434,"marketCap":220783733257},{"date":"2021-05-14","current":20.973664,"twenty":11.409861,"median":20.760105,"eighty":24.37434,"marketCap":224019708557},{"date":"2021-05-21","current":20.936979,"twenty":11.409861,"median":20.760105,"eighty":24.37434,"marketCap":223627869986},{"date":"2021-05-28","current":20.297602,"twenty":11.409861,"median":20.716502,"eighty":24.37434,"marketCap":216798683468},{"date":"2021-06-04","current":20.517715,"twenty":11.409861,"median":20.692277,"eighty":24.37434,"marketCap":219149714893},{"date":"2021-06-11","current":21.041795,"twenty":11.409861,"median":20.672898,"eighty":24.37434,"marketCap":224747408760},{"date":"2021-06-18","current":20.339528,"twenty":11.409861,"median":20.65811,"eighty":24.37434,"marketCap":217246498978},{"date":"2021-06-25","current":20.428622,"twenty":11.409861,"median":20.596327,"eighty":24.37434,"marketCap":218198106935},{"date":"2021-07-02","current":20.821681,"twenty":11.409861,"median":20.580846,"eighty":24.37434,"marketCap":222396377335},{"date":"2021-07-09","current":20.758792,"twenty":11.409861,"median":20.579237,"eighty":24.37434,"marketCap":221724654071},{"date":"2021-07-16","current":21.146611,"twenty":11.409861,"median":20.579237,"eighty":24.367449,"marketCap":225866947533},{"date":"2021-07-23","current":21.843636,"twenty":11.409861,"median":20.579237,"eighty":24.367449,"marketCap":233311880376},{"date":"2021-07-30","current":18.78624,"twenty":11.409861,"median":20.542088,"eighty":24.365286,"marketCap":239637274446},{"date":"2021-08-06","current":19.777992,"twenty":11.409861,"median":20.503796,"eighty":24.357982,"marketCap":252288062585},{"date":"2021-08-13","current":21.30858,"twenty":11.409861,"median":20.491511,"eighty":24.357982,"marketCap":271812251498},{"date":"2021-08-20","current":21.414068,"twenty":11.409861,"median":20.491511,"eighty":24.357982,"marketCap":273157856704},{"date":"2021-08-27","current":20.482258,"twenty":11.409861,"median":20.482258,"eighty":24.357982,"marketCap":261271677389},{"date":"2021-09-03","current":20.587746,"twenty":11.409861,"median":20.467021,"eighty":24.357982,"marketCap":262617282595},{"date":"2021-09-10","current":20.038329,"twenty":11.409861,"median":20.455205,"eighty":24.357982,"marketCap":255608922150},{"date":"2021-09-17","current":19.291122,"twenty":11.409861,"median":20.423381,"eighty":24.357982,"marketCap":246077551944},{"date":"2021-09-24","current":19.313099,"twenty":11.409861,"median":20.369394,"eighty":24.357982,"marketCap":246357886362},{"date":"2021-10-01","current":18.86917,"twenty":11.409861,"median":20.329046,"eighty":24.357982,"marketCap":240695131123},{"date":"2021-10-08","current":18.658194,"twenty":11.409861,"median":20.299846,"eighty":24.357982,"marketCap":238003920712},{"date":"2021-10-15","current":18.236242,"twenty":11.409861,"median":20.236119,"eighty":24.357982,"marketCap":232621499890},{"date":"2021-10-22","current":18.970263,"twenty":11.409861,"median":20.177063,"eighty":24.357982,"marketCap":241984669444},{"date":"2021-10-29","current":19.225192,"twenty":11.409861,"median":20.091518,"eighty":24.357982,"marketCap":245236548691},{"date":"2021-11-05","current":14.025377,"twenty":11.409861,"median":19.896498,"eighty":24.357982,"marketCap":272541120985},{"date":"2021-11-12","current":14.36434,"twenty":11.409861,"median":19.777992,"eighty":24.357982,"marketCap":279127855918},{"date":"2021-11-19","current":14.673406,"twenty":11.409861,"median":19.717295,"eighty":24.357982,"marketCap":285133623178},{"date":"2021-11-26","current":15.597715,"twenty":11.409861,"median":19.677911,"eighty":24.357982,"marketCap":303094796292},{"date":"2021-12-03","current":15.675703,"twenty":11.409861,"median":19.602804,"eighty":24.357982,"marketCap":304610270273},{"date":"2021-12-10","current":15.245322,"twenty":11.409861,"median":19.422982,"eighty":24.357982,"marketCap":296247099042},{"date":"2021-12-17","current":17.180594,"twenty":11.409861,"median":19.291122,"eighty":24.357982,"marketCap":333853305249},{"date":"2021-12-23","current":16.958182,"twenty":11.409861,"median":19.150471,"eighty":24.357982,"marketCap":329531397968},{"date":"2021-12-31","current":17.05639,"twenty":11.409861,"median":18.970263,"eighty":24.357982,"marketCap":331439772611},{"date":"2022-01-07","current":16.094531,"twenty":11.412076,"median":18.877961,"eighty":24.349074,"marketCap":312748926840},{"date":"2022-01-14","current":15.872119,"twenty":11.412076,"median":18.781561,"eighty":24.349074,"marketCap":308427019560},{"date":"2022-01-21","current":15.248211,"twenty":11.412076,"median":18.550508,"eighty":24.349074,"marketCap":296303227708},{"date":"2022-01-28","current":15.693034,"twenty":11.412076,"median":18.2758,"eighty":24.349074,"marketCap":304947042269},{"date":"2022-02-04","current":15.308868,"twenty":11.412076,"median":17.658635,"eighty":24.349074,"marketCap":297481929694},{"date":"2022-02-11","current":12.967895,"twenty":11.412076,"median":17.063675,"eighty":24.349074,"marketCap":285021365846},{"date":"2022-02-18","current":12.393303,"twenty":11.412076,"median":16.913411,"eighty":24.304908,"marketCap":272392416000},{"date":"2022-02-25","current":12.209204,"twenty":11.412076,"median":16.666775,"eighty":24.28572,"marketCap":268346093596},{"date":"2022-03-04","current":12.447145,"twenty":11.412076,"median":16.350479,"eighty":24.223896,"marketCap":273575805814},{"date":"2022-03-11","current":12.861624,"twenty":11.412076,"median":16.242465,"eighty":24.163866,"marketCap":282685627097},{"date":"2022-03-18","current":13.946431,"twenty":11.412076,"median":16.098985,"eighty":24.106879,"marketCap":306528616134},{"date":"2022-03-25","current":13.503809,"twenty":11.412076,"median":16.055537,"eighty":24.034221,"marketCap":296800226739},{"date":"2022-04-01","current":13.19423,"twenty":11.412076,"median":15.959151,"eighty":23.843315,"marketCap":289995977509},{"date":"2022-04-08","current":14.115293,"twenty":11.412076,"median":15.941662,"eighty":23.723395,"marketCap":310240024805},{"date":"2022-04-14","current":13.590799,"twenty":11.412076,"median":15.900125,"eighty":23.573362,"marketCap":298712164539},{"date":"2022-04-22","current":12.314103,"twenty":11.412076,"median":15.858587,"eighty":23.512736,"marketCap":270651665649},{"date":"2022-04-29","current":12.554603,"twenty":11.412076,"median":15.790815,"eighty":22.633009,"marketCap":275937611331},{"date":"2022-05-06","current":11.045779,"twenty":11.377811,"median":15.703367,"eighty":22.453679,"marketCap":275768910937},{"date":"2022-05-13","current":11.219095,"twenty":11.321022,"median":15.657458,"eighty":22.360096,"marketCap":280095918385},{"date":"2022-05-20","current":11.792185,"twenty":11.321022,"median":15.601352,"eighty":22.291941,"marketCap":294403702678},{"date":"2022-05-27","current":12.115813,"twenty":11.321022,"median":15.49568,"eighty":22.218192,"marketCap":302483392631},{"date":"2022-06-03","current":11.956247,"twenty":11.321022,"median":15.456215,"eighty":22.152127,"marketCap":298499656613},{"date":"2022-06-10","current":11.230332,"twenty":11.312153,"median":15.377007,"eighty":22.082449,"marketCap":280376463175},{"date":"2022-06-17","current":10.457221,"twenty":11.246327,"median":15.324755,"eighty":21.997212,"marketCap":261074981620},{"date":"2022-06-24","current":11.594413,"twenty":11.225837,"median":15.248211,"eighty":21.941859,"marketCap":289466114373},{"date":"2022-07-01","current":11.756227,"twenty":11.225837,"median":15.219326,"eighty":21.878005,"marketCap":293505959350},{"date":"2022-07-08","current":11.949505,"twenty":11.225837,"median":15.168412,"eighty":21.831359,"marketCap":298331329739},{"date":"2022-07-15","current":11.630372,"twenty":11.225837,"median":15.075933,"eighty":21.74118,"marketCap":290363857701},{"date":"2022-07-22","current":11.513506,"twenty":11.225837,"median":15.043129,"eighty":21.652794,"marketCap":287446191885},{"date":"2022-07-29","current":9.669931,"twenty":11.215862,"median":15.01571,"eighty":21.581005,"marketCap":283406346908},{"date":"2022-08-05","current":9.432538,"twenty":11.166146,"median":14.985989,"eighty":21.512019,"marketCap":276448836115},{"date":"2022-08-12","current":9.595842,"twenty":11.131952,"median":14.907651,"eighty":21.443472,"marketCap":281234949148},{"date":"2022-08-19","current":9.412007,"twenty":11.0455,"median":14.852815,"eighty":21.354014,"marketCap":275847091412},{"date":"2022-08-26","current":8.965822,"twenty":11.017001,"median":14.805812,"eighty":21.321791,"marketCap":262770311697},{"date":"2022-09-02","current":8.751347,"twenty":10.97228,"median":14.699402,"eighty":21.273106,"marketCap":256484477671},{"date":"2022-09-09","current":9.161147,"twenty":10.950031,"median":14.660888,"eighty":21.227382,"marketCap":268494910542},{"date":"2022-09-16","current":8.814541,"twenty":10.914418,"median":14.476794,"eighty":21.18126,"marketCap":258336553768},{"date":"2022-09-23","current":8.441124,"twenty":10.844223,"median":14.421958,"eighty":21.144824,"marketCap":247392467740},{"date":"2022-09-30","current":8.379846,"twenty":10.790275,"median":14.374955,"eighty":21.126333,"marketCap":245596515161},{"date":"2022-10-07","current":8.104092,"twenty":10.768631,"median":14.316202,"eighty":21.072492,"marketCap":237514728556},{"date":"2022-10-14","current":8.2075,"twenty":10.734827,"median":14.245698,"eighty":21.041795,"marketCap":240545398533},{"date":"2022-10-21","current":8.607725,"twenty":10.699722,"median":14.16736,"eighty":21.017687,"marketCap":252275213814},{"date":"2022-10-28","current":9.082634,"twenty":10.659445,"median":14.112734,"eighty":20.988442,"marketCap":266193846300},{"date":"2022-11-04","current":8.901792,"twenty":10.621799,"median":14.006768,"eighty":20.960547,"marketCap":265015252420},{"date":"2022-11-11","current":8.974968,"twenty":10.584832,"median":13.879672,"eighty":20.925828,"marketCap":267193771961},{"date":"2022-11-18","current":9.093754,"twenty":10.560165,"median":13.798038,"eighty":20.887265,"marketCap":270730160119},{"date":"2022-11-25","current":9.278533,"twenty":10.525451,"median":13.674906,"eighty":20.874204,"marketCap":276231208365},{"date":"2022-12-02","current":9.599068,"twenty":10.488819,"median":13.589588,"eighty":20.863738,"marketCap":285773843078},{"date":"2022-12-09","current":9.751793,"twenty":10.453561,"median":13.569587,"eighty":20.837349,"marketCap":290320627853},{"date":"2022-12-16","current":9.691457,"twenty":10.410193,"median":13.503809,"eighty":20.82389,"marketCap":288524367201},{"date":"2022-12-23","current":9.772533,"twenty":10.366422,"median":13.455198,"eighty":20.795407,"marketCap":290938092452},{"date":"2022-12-30","current":9.661289,"twenty":10.34012,"median":13.432165,"eighty":20.776578,"marketCap":287626236875},{"date":"2023-01-06","current":9.600953,"twenty":10.304932,"median":13.41682,"eighty":20.763011,"marketCap":285829976224},{"date":"2023-01-13","current":9.022105,"twenty":10.285152,"median":13.368208,"eighty":20.746667,"marketCap":268597100595},{"date":"2023-01-20","current":8.505479,"twenty":10.273114,"median":13.35752,"eighty":20.71844,"marketCap":253216618764},{"date":"2023-01-27","current":8.256593,"twenty":10.265725,"median":13.294343,"eighty":20.680003,"marketCap":245807043575},{"date":"2023-02-03","current":7.883547,"twenty":10.235468,"median":13.287287,"eighty":20.672898,"marketCap":247322638500},{"date":"2023-02-10","current":7.85134,"twenty":10.235468,"median":13.287287,"eighty":20.672898,"marketCap":246312241883},{"date":"2023-02-17","current":7.731459,"twenty":10.235468,"median":13.287287,"eighty":20.672898,"marketCap":242551321143},{"date":"2023-02-24","current":7.47789,"twenty":10.235468,"median":13.287287,"eighty":20.672898,"marketCap":234596365426},{"date":"2023-03-03","current":7.370423,"twenty":10.227112,"median":13.287287,"eighty":20.672898,"marketCap":231224920654},{"date":"2023-03-10","current":7.055188,"twenty":10.223818,"median":13.287287,"eighty":20.672898,"marketCap":221335349321},{"date":"2023-03-17","current":7.214731,"twenty":10.211706,"median":13.287287,"eighty":20.672898,"marketCap":226340534916},{"date":"2023-03-24","current":7.266907,"twenty":10.211706,"median":13.287287,"eighty":20.672898,"marketCap":227977411603},{"date":"2023-03-31","current":7.340674,"twenty":10.20121,"median":13.286569,"eighty":20.672898,"marketCap":230291616573},{"date":"2023-04-06","current":7.475613,"twenty":10.20121,"median":13.286569,"eighty":20.672898,"marketCap":234524918348},{"date":"2023-04-14","current":7.461219,"twenty":10.211706,"median":13.287287,"eighty":20.672898,"marketCap":234073366159},{"date":"2023-04-21","current":7.169751,"twenty":10.195184,"median":13.287287,"eighty":20.672898,"marketCap":224929434324},{"date":"2023-04-28","current":6.970042,"twenty":10.128354,"median":13.287287,"eighty":20.672898,"marketCap":218664147697},{"date":"2023-05-05","current":7.427817,"twenty":10.119305,"median":13.287287,"eighty":20.672898,"marketCap":215785502490},{"date":"2023-05-12","current":7.301526,"twenty":10.119305,"median":13.287287,"eighty":20.672898,"marketCap":212116640951},{"date":"2023-05-19","current":7.08894,"twenty":10.119305,"median":13.287287,"eighty":20.672898,"marketCap":205940800089},{"date":"2023-05-26","current":7.351278,"twenty":10.119305,"median":13.287287,"eighty":20.672898,"marketCap":213561964566},{"date":"2023-06-02","current":7.388199,"twenty":10.119305,"median":13.287287,"eighty":20.672898,"marketCap":214634572900},{"date":"2023-06-09","current":7.596126,"twenty":10.119305,"median":13.287287,"eighty":20.672898,"marketCap":220675051411},{"date":"2023-06-16","current":7.72438,"twenty":10.119305,"median":13.287287,"eighty":20.672898,"marketCap":224400954045},{"date":"2023-06-23","current":7.526169,"twenty":10.131582,"median":13.294343,"eighty":20.672898,"marketCap":218642740884},{"date":"2023-06-30","current":7.018983,"twenty":10.140189,"median":13.296923,"eighty":20.672898,"marketCap":203908489562},{"date":"2023-07-07","current":6.923765,"twenty":10.140189,"median":13.296923,"eighty":20.672898,"marketCap":201142289122},{"date":"2023-07-14","current":7.007324,"twenty":10.140189,"median":13.296923,"eighty":20.672898,"marketCap":203569771141},{"date":"2023-07-21","current":7.145294,"twenty":10.140189,"median":13.296923,"eighty":20.672898,"marketCap":207577939125},{"date":"2023-07-28","current":7.034529,"twenty":9.937466,"median":13.296923,"eighty":20.672898,"marketCap":204360114124},{"date":"2023-08-04","current":9.20159,"twenty":9.822311,"median":13.299503,"eighty":20.676451,"marketCap":197585745700},{"date":"2023-08-11","current":9.391966,"twenty":9.731394,"median":13.299503,"eighty":20.676451,"marketCap":201673675840},{"date":"2023-08-18","current":9.599683,"twenty":9.677882,"median":13.299503,"eighty":20.676451,"marketCap":206133983900},{"date":"2023-08-25","current":9.507656,"twenty":9.664306,"median":13.299503,"eighty":20.676451,"marketCap":204157898051},{"date":"2023-09-01","current":9.302568,"twenty":9.625087,"median":13.299503,"eighty":20.676451,"marketCap":199754049586},{"date":"2023-09-08","current":9.013342,"twenty":9.597778,"median":13.311036,"eighty":20.680003,"marketCap":193543494059},{"date":"2023-09-15","current":8.979161,"twenty":9.565322,"median":13.322569,"eighty":20.683556,"marketCap":192809519315},{"date":"2023-09-22","current":8.637348,"twenty":9.536302,"median":13.322569,"eighty":20.683556,"marketCap":185469771874},{"date":"2023-09-29","current":8.437519,"twenty":9.506079,"median":13.322569,"eighty":20.683556,"marketCap":181178842601},{"date":"2023-10-06","current":8.800366,"twenty":9.474085,"median":13.322569,"eighty":20.683556,"marketCap":188970266807},{"date":"2023-10-13","current":8.655753,"twenty":9.433517,"median":13.322569,"eighty":20.683556,"marketCap":185864989044},{"date":"2023-10-20","current":8.200879,"twenty":9.395121,"median":13.326394,"eighty":20.687108,"marketCap":176097478988},{"date":"2023-10-27","current":8.192991,"twenty":9.371624,"median":13.352857,"eighty":20.691307,"marketCap":175928100201},{"date":"2023-11-03","current":16.428331,"twenty":9.363832,"median":13.357974,"eighty":20.691307,"marketCap":172201766885},{"date":"2023-11-10","current":15.987936,"twenty":9.363832,"median":13.388235,"eighty":20.691307,"marketCap":167585546506},{"date":"2023-11-17","current":16.036417,"twenty":9.363832,"median":13.431944,"eighty":20.691307,"marketCap":168093723702},{"date":"2023-11-24","current":16.429651,"twenty":9.363832,"median":13.449665,"eighty":20.691307,"marketCap":172215605406},{"date":"2023-12-01","current":16.413491,"twenty":9.363832,"median":13.493575,"eighty":20.691307,"marketCap":172046213007},{"date":"2023-12-08","current":15.422325,"twenty":9.363982,"median":13.545766,"eighty":20.690984,"marketCap":161656812549},{"date":"2023-12-15","current":14.075632,"twenty":9.363982,"median":13.586961,"eighty":20.690984,"marketCap":147540779319},{"date":"2023-12-22","current":15.249949,"twenty":9.363982,"median":13.63957,"eighty":20.690984,"marketCap":159849960296},{"date":"2023-12-29","current":15.508514,"twenty":9.363832,"median":13.71586,"eighty":20.691307,"marketCap":162560238676},{"date":"2024-01-05","current":15.670117,"twenty":9.363681,"median":13.842132,"eighty":20.691631,"marketCap":164254162664},{"date":"2024-01-12","current":15.298429,"twenty":9.363681,"median":13.918956,"eighty":20.691631,"marketCap":160358137492},{"date":"2024-01-19","current":15.13144,"twenty":9.363531,"median":14.025377,"eighty":20.691954,"marketCap":158607749372},{"date":"2024-01-26","current":14.79746,"twenty":9.363681,"median":14.11067,"eighty":20.691631,"marketCap":155106973131},{"date":"2024-02-02","current":72.718555,"twenty":9.363681,"median":14.114013,"eighty":20.691631,"marketCap":154090618738},{"date":"2024-02-09","current":73.46466,"twenty":9.363681,"median":14.114013,"eighty":20.691631,"marketCap":155671614460},{"date":"2024-02-16","current":73.30478,"twenty":9.363681,"median":14.114013,"eighty":20.691631,"marketCap":155332829662},{"date":"2024-02-23","current":73.411367,"twenty":9.363681,"median":14.114013,"eighty":20.691631,"marketCap":155558686194},{"date":"2024-03-01","current":70.777931,"twenty":9.363832,"median":14.115293,"eighty":20.698091,"marketCap":149978434968},{"date":"2024-03-08","current":71.390842,"twenty":9.363832,"median":14.115293,"eighty":20.70875,"marketCap":151277194005},{"date":"2024-03-15","current":75.170971,"twenty":9.363832,"median":14.115293,"eighty":20.724066,"marketCap":159287286515},{"date":"2024-03-22","current":73.915003,"twenty":9.363832,"median":14.115293,"eighty":20.724066,"marketCap":156625892109},{"date":"2024-03-28","current":74.235676,"twenty":9.363832,"median":14.115293,"eighty":20.724066,"marketCap":157305397063},{"date":"2024-04-05","current":71.21601,"twenty":9.363681,"median":14.114013,"eighty":20.719408,"marketCap":150906725405},{"date":"2024-04-12","current":70.387606,"twenty":9.363681,"median":14.114013,"eighty":20.719408,"marketCap":149151337604},{"date":"2024-04-19","current":67.848949,"twenty":9.363681,"median":14.114013,"eighty":20.740378,"marketCap":143771923378},{"date":"2024-04-26","current":67.501554,"twenty":9.363832,"median":14.115293,"eighty":20.761487,"marketCap":143035793010},{"date":"2024-05-03","current":-507.612925,"twenty":9.362812,"median":14.112734,"eighty":20.779592,"marketCap":156852393760},{"date":"2024-05-10","current":-516.778602,"twenty":9.30426,"median":14.025377,"eighty":20.779592,"marketCap":159684587865},{"date":"2024-05-17","current":-530.349083,"twenty":9.281927,"median":13.893323,"eighty":20.779592,"marketCap":163877866610},{"date":"2024-05-24","current":-526.131231,"twenty":9.204745,"median":13.825068,"eighty":20.779592,"marketCap":162574550243},{"date":"2024-05-31","current":-525.581076,"twenty":9.159833,"median":13.705621,"eighty":20.779592,"marketCap":162404552456},{"date":"2024-06-07","current":-524.113997,"twenty":9.089983,"median":13.590799,"eighty":20.779592,"marketCap":161951225024},{"date":"2024-06-14","current":-504.858584,"twenty":9.039275,"median":13.569587,"eighty":20.765845,"marketCap":156001302481},{"date":"2024-06-21","current":-508.709667,"twenty":8.98578,"median":13.521784,"eighty":20.754599,"marketCap":157191286990},{"date":"2024-06-28","current":-513.110904,"twenty":8.962782,"median":13.472518,"eighty":20.71747,"marketCap":158551269286},{"date":"2024-07-05","current":-514.394598,"twenty":8.934929,"median":13.440977,"eighty":20.672018,"marketCap":158947930788},{"date":"2024-07-12","current":-530.349083,"twenty":8.918049,"median":13.417885,"eighty":20.596051,"marketCap":163877866610},{"date":"2024-07-19","current":-549.604496,"twenty":8.86111,"median":13.369689,"eighty":20.584342,"marketCap":169827789153},{"date":"2024-07-26","current":-564.275286,"twenty":8.835222,"median":13.355189,"eighty":20.544384,"marketCap":174361063471},{"date":"2024-08-02","current":-66.448717,"twenty":8.79853,"median":13.290815,"eighty":20.532389,"marketCap":172434421886},{"date":"2024-08-09","current":-62.344564,"twenty":8.758581,"median":13.273907,"eighty":20.532389,"marketCap":161784144077},{"date":"2024-08-16","current":-61.79864,"twenty":8.724641,"median":13.26317,"eighty":20.532389,"marketCap":160367470311},{"date":"2024-08-23","current":-63.108858,"twenty":8.703219,"median":13.229071,"eighty":20.532389,"marketCap":163767487349},{"date":"2024-08-30","current":-63.349065,"twenty":8.64471,"median":13.199807,"eighty":20.532389,"marketCap":164390823806},{"date":"2024-09-06","current":-62.366401,"twenty":8.582065,"median":13.181181,"eighty":20.532389,"marketCap":161840811027},{"date":"2024-09-13","current":-63.916826,"twenty":8.506547,"median":13.146044,"eighty":20.532389,"marketCap":165864164523},{"date":"2024-09-20","current":-64.244381,"twenty":8.464745,"median":13.128514,"eighty":20.532389,"marketCap":166714168782},{"date":"2024-09-27","current":-63.523761,"twenty":8.442882,"median":13.084276,"eighty":20.532389,"marketCap":164844159411},{"date":"2024-10-04","current":-62.410075,"twenty":8.418315,"median":13.067436,"eighty":20.532389,"marketCap":161954144929},{"date":"2024-10-11","current":-63.67662,"twenty":8.291286,"median":13.036677,"eighty":20.532389,"marketCap":165240828066},{"date":"2024-10-18","current":-63.807642,"twenty":8.213635,"median":13.000349,"eighty":20.532389,"marketCap":165580829770},{"date":"2024-10-25","current":-62.126194,"twenty":8.076974,"median":12.960452,"eighty":20.532389,"marketCap":161217474570},{"date":"2024-11-01","current":37.435904,"twenty":8.052693,"median":12.949029,"eighty":20.563107,"marketCap":159177464347},{"date":"2024-11-08","current":35.611941,"twenty":8.052693,"median":12.977944,"eighty":20.593816,"marketCap":151421973735},{"date":"2024-11-15","current":33.052999,"twenty":8.052693,"median":13.032739,"eighty":20.666106,"marketCap":140541352868},{"date":"2024-11-22","current":34.185864,"twenty":8.052693,"median":13.067436,"eighty":20.754599,"marketCap":145358294397},{"date":"2024-11-29","current":34.932222,"twenty":8.052693,"median":13.067436,"eighty":20.775562,"marketCap":148531808817},{"date":"2024-12-06","current":34.292487,"twenty":8.052693,"median":13.095443,"eighty":20.826266,"marketCap":145811653600},{"date":"2024-12-13","current":34.092569,"twenty":8.052693,"median":13.135764,"eighty":20.870026,"marketCap":144961605095},{"date":"2024-12-20","current":35.13214,"twenty":8.052693,"median":13.141793,"eighty":20.911389,"marketCap":149381857322},{"date":"2024-12-27","current":35.478663,"twenty":8.052693,"median":13.141793,"eighty":20.942753,"marketCap":150855274731},{"date":"2025-01-03","current":35.438679,"twenty":8.052693,"median":13.141793,"eighty":20.985349,"marketCap":150685265030},{"date":"2025-01-10","current":35.611941,"twenty":8.050625,"median":13.139483,"eighty":21.025024,"marketCap":151421973735},{"date":"2025-01-17","current":35.052173,"twenty":8.050625,"median":13.139483,"eighty":21.080518,"marketCap":149041837920},{"date":"2025-01-24","current":34.772288,"twenty":8.050625,"median":13.139483,"eighty":21.146015,"marketCap":147851770013},{"date":"2025-01-31","current":35.345385,"twenty":8.050625,"median":13.146158,"eighty":21.216458,"marketCap":150288575728},{"date":"2025-02-07","current":18.163158,"twenty":8.050625,"median":13.19423,"eighty":21.232237,"marketCap":145868323500},{"date":"2025-02-14","current":18.014974,"twenty":8.050625,"median":13.244948,"eighty":21.232237,"marketCap":144678255593},{"date":"2025-02-21","current":18.558316,"twenty":8.050625,"median":13.26331,"eighty":21.232237,"marketCap":149041837920},{"date":"2025-02-28","current":18.651202,"twenty":8.050625,"median":13.322569,"eighty":21.232237,"marketCap":149787807142},{"date":"2025-03-07","current":18.862907,"twenty":8.048558,"median":13.39792,"eighty":21.234665,"marketCap":151488009266},{"date":"2025-03-14","current":18.163344,"twenty":8.048558,"median":13.462976,"eighty":21.234665,"marketCap":145869816607},{"date":"2025-03-21","current":18.558814,"twenty":8.048558,"median":13.521784,"eighty":21.234665,"marketCap":149045831276},{"date":"2025-03-28","current":17.803184,"twenty":8.048558,"median":13.569959,"eighty":21.234665,"marketCap":142977374676},{"date":"2025-04-04","current":16.221307,"twenty":8.048558,"median":13.618281,"eighty":21.234665,"marketCap":130273315997},{"date":"2025-04-11","current":15.47274,"twenty":8.050625,"median":13.877352,"eighty":21.232237,"marketCap":124261573944},{"date":"2025-04-17","current":15.635165,"twenty":8.050625,"median":14.006768,"eighty":21.232237,"marketCap":125566008541},{"date":"2025-04-25","current":16.185997,"twenty":8.048558,"median":14.11067,"eighty":21.234665,"marketCap":129989743259},{"date":"2025-05-02","current":17.410783,"twenty":8.048558,"median":14.155517,"eighty":21.234665,"marketCap":137249205361},{"date":"2025-05-09","current":16.068749,"twenty":8.048558,"median":14.24374,"eighty":21.234665,"marketCap":126669945278},{"date":"2025-05-16","current":16.465419,"twenty":8.048558,"median":14.300535,"eighty":21.234665,"marketCap":129796896351},{"date":"2025-05-23","current":16.616875,"twenty":8.048558,"median":14.354334,"eighty":21.234665,"marketCap":130990823124},{"date":"2025-05-30","current":16.912574,"twenty":8.048558,"median":14.400415,"eighty":21.234665,"marketCap":133321823015},{"date":"2025-06-06","current":16.674572,"twenty":8.048558,"median":14.441542,"eighty":21.234665,"marketCap":131445652371},{"date":"2025-06-13","current":17.915068,"twenty":8.048558,"median":14.487372,"eighty":21.234665,"marketCap":141224481181},{"date":"2025-06-20","current":17.222698,"twenty":8.045367,"median":14.660888,"eighty":21.240657,"marketCap":135766530217},{"date":"2025-06-27","current":17.482337,"twenty":8.045367,"median":14.754283,"eighty":21.240657,"marketCap":137813261828},{"date":"2025-07-03","current":18.304526,"twenty":8.045367,"median":14.801895,"eighty":21.240657,"marketCap":144294578598},{"date":"2025-07-11","current":18.593013,"twenty":8.045367,"median":14.848898,"eighty":21.240657,"marketCap":146568724832},{"date":"2025-07-18","current":17.727551,"twenty":8.045367,"median":14.883648,"eighty":21.240657,"marketCap":139746286128},{"date":"2025-07-25","current":18.282889,"twenty":8.045367,"median":14.950737,"eighty":21.240657,"marketCap":144124017630},{"date":"2025-08-01","current":16.797179,"twenty":8.045367,"median":14.954654,"eighty":21.240657,"marketCap":132412164521},{"date":"2025-08-08","current":12.812583,"twenty":8.045367,"median":14.907651,"eighty":21.240657,"marketCap":137760888615},{"date":"2025-08-15","current":13.277918,"twenty":8.045367,"median":14.869822,"eighty":21.240657,"marketCap":142764173055},{"date":"2025-08-22","current":13.611056,"twenty":8.045367,"median":14.846714,"eighty":21.240657,"marketCap":146346069870},{"date":"2025-08-29","current":13.008235,"twenty":8.045367,"median":14.79746,"eighty":21.240657,"marketCap":139864542300},{"date":"2025-09-05","current":12.976508,"twenty":8.042176,"median":14.793202,"eighty":21.24665,"marketCap":139523409270},{"date":"2025-09-12","current":13.14572,"twenty":8.045367,"median":14.788945,"eighty":21.240657,"marketCap":141342785430},{"date":"2025-09-19","current":12.770279,"twenty":8.045367,"median":14.788945,"eighty":21.240657,"marketCap":137306044575},{"date":"2025-09-26","current":12.479445,"twenty":8.045367,"median":14.788945,"eighty":21.240657,"marketCap":134178991800},{"date":"2025-10-03","current":14.319634,"twenty":8.045367,"median":14.788945,"eighty":21.240657,"marketCap":153964707540},{"date":"2025-10-10","current":13.346661,"twenty":8.045367,"median":14.788945,"eighty":21.240657,"marketCap":143503294620},{"date":"2025-10-17","current":12.812583,"twenty":8.045367,"median":14.754283,"eighty":21.240657,"marketCap":137760888615},{"date":"2025-10-24","current":13.04525,"twenty":8.045367,"median":14.693625,"eighty":21.240657,"marketCap":140262530835},{"date":"2025-10-31","current":12.84431,"twenty":8.045367,"median":14.388377,"eighty":21.173977,"marketCap":138102021645},{"date":"2025-11-07","current":14.374792,"twenty":8.045367,"median":14.341232,"eighty":21.132722,"marketCap":141289832667},{"date":"2025-11-14","current":14.918547,"twenty":8.045367,"median":14.319634,"eighty":21.041795,"marketCap":146634397766},{"date":"2025-11-21","current":14.114484,"twenty":8.045367,"median":14.235961,"eighty":20.99358,"marketCap":138731264268},{"date":"2025-11-28","current":14.87227,"twenty":8.045367,"median":14.235961,"eighty":20.948935,"marketCap":146179541161},{"date":"2025-12-05","current":14.866485,"twenty":8.045367,"median":14.235961,"eighty":20.904384,"marketCap":146122684086},{"date":"2025-12-12","current":14.924332,"twenty":8.045367,"median":14.235961,"eighty":20.865963,"marketCap":146691254841},{"date":"2025-12-19","current":14.4847,"twenty":8.045367,"median":14.235961,"eighty":20.825485,"marketCap":142370117102},{"date":"2025-12-26","current":14.478915,"twenty":8.045367,"median":14.235961,"eighty":20.782133,"marketCap":142313260026},{"date":"2026-01-02","current":14.403715,"twenty":8.045367,"median":14.235961,"eighty":20.758792,"marketCap":141574118044},{"date":"2026-01-09","current":14.629316,"twenty":8.045367,"median":14.235961,"eighty":20.674691,"marketCap":143791543990},{"date":"2026-01-16","current":14.976393,"twenty":8.045367,"median":14.235961,"eighty":20.595774,"marketCap":147202968521},{"date":"2026-01-23","current":15.09787,"twenty":8.045367,"median":14.235961,"eighty":20.580939,"marketCap":148396967107},{"date":"2026-01-30","current":15.09787,"twenty":8.045367,"median":14.235961,"eighty":20.54058,"marketCap":148396967107},{"date":"2026-02-06","current":19.381597,"twenty":8.045367,"median":14.235961,"eighty":20.493607,"marketCap":150614393052},{"date":"2026-02-13","current":20.098621,"twenty":8.045367,"median":14.235961,"eighty":20.447221,"marketCap":156186386453},{"date":"2026-02-20","current":19.65231,"twenty":8.045367,"median":14.235961,"eighty":20.410159,"marketCap":152718104846},{"date":"2026-02-23","current":19.498662,"twenty":8.045367,"median":14.235961,"eighty":20.399112,"marketCap":151524106260}],"updateTime":1771945927869},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PFE\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2614721327","title":"先為達生物與輝瑞中國就GLP-1藥物達成合作；三生國健2025年度歸母淨利潤增長317.09% | 醫藥早參","url":"https://stock-news.laohu8.com/highlight/detail?id=2614721327","media":"每日经济新闻","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614721327?lang=zh_tw&edition=fundamental","pubTime":"2026-02-25 07:03","pubTimestamp":1771974219,"startTime":"0","endTime":"0","summary":"丨2026年2月25日星期三丨NO.1先为达生物与辉瑞中国就GLP-1药物达成合作2月24日，“先为达生物”微信公众号发布消息，宣布与辉瑞中国就新一代偏向型GLP-1受体激动剂埃诺格鲁肽注射液达成商业化战略合作协议。先为达生物将有权获得辉瑞支付的最高可达4.95亿美元的付款总额，包括首付款、注册及销售里程碑付款。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202602253653144565.html","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202602253653144565.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4144","BK1161","BK4585","SG9999001176.USD","LU0170899867.USD","LU0456855351.SGD","LU0868494617.USD","IE0002270589.USD","BK4599","BK4568","LU0122379950.USD","LU0225771236.USD","LU1066051498.USD","BK4550","688336","LU0985481810.HKD","IE00B19Z3581.USD","LU1057294990.SGD","IE00BBT3K403.USD","SG9999013999.USD","BK4534","LU0306807586.USD","LU0321505439.SGD","IE000M9KFDE8.USD","BK4007","LU1883839398.USD","LU1894683264.USD","LU1894683348.USD","PFE","SGXZ57979304.SGD","IE00BLSP4239.USD","LU0234572021.USD","SG9999003800.SGD","BK1574","BK4581","LU0321505868.SGD","IE00BLSP4452.SGD","BK4590","BK4588","IE00B19Z3B42.SGD","SG9999002224.SGD","LU0058720904.USD","SG9999011175.SGD","LU1023059063.AUD","LU1066053197.SGD","91078","BK4533","BK1515","LU0306806265.USD","SG9999001176.SGD","LU0225284248.USD","SG9999002232.USD","BK0239","BK4592","LU0289739699.SGD"],"gpt_icon":0},{"id":"1149231277","title":"美國FDA全面批准輝瑞Braftovi聯合療法用於一線治療轉移性結直腸癌","url":"https://stock-news.laohu8.com/highlight/detail?id=1149231277","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1149231277?lang=zh_tw&edition=fundamental","pubTime":"2026-02-25 03:30","pubTimestamp":1771961452,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局（FDA）已正式授予辉瑞公司Braftovi联合疗法完全批准，该疗法将作为转移性结直肠癌的一线治疗方案。此次全面批准标志着该组合疗法在临床应用中迈出关键一步，为患者提供了新的治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0002270589.USD","SG9999001176.SGD","BK4588","SG9999002232.USD","IE00B19Z3581.USD","LU0234572021.USD","LU1023059063.AUD","IE00B19Z3B42.SGD","LU0289739699.SGD","LU0868494617.USD","LU1894683264.USD","BK4533","LU0306807586.USD","SG9999013999.USD","BK4568","SG9999003800.SGD","LU0058720904.USD","LU0456855351.SGD","SG9999001176.USD","LU1883839398.USD","PFE","LU0306806265.USD","BK4585","LU1894683348.USD","SG9999002224.SGD","LU0321505439.SGD","BK4534","BK4599","SG9999011175.SGD","IE000M9KFDE8.USD","LU0321505868.SGD","LU0122379950.USD","IE00BLSP4452.SGD","BK4550","LU1057294990.SGD","LU0225284248.USD","LU0985481810.HKD","LU1066053197.SGD","BK4007","IE00BBT3K403.USD","BK4592","LU0170899867.USD","IE00BLSP4239.USD","SGXZ57979304.SGD","BK4581","LU0225771236.USD","LU1066051498.USD"],"gpt_icon":0},{"id":"1195345777","title":"FDA正式批准Encorafenib用於治療BRAF V600E突變型轉移性結直腸癌","url":"https://stock-news.laohu8.com/highlight/detail?id=1195345777","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195345777?lang=zh_tw&edition=fundamental","pubTime":"2026-02-25 01:57","pubTimestamp":1771955860,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局（FDA）已正式授予Encorafenib传统批准，用于治疗携带BRAF V600E突变的转移性结直肠癌患者。这一决定为特定基因突变类型的晚期结直肠癌患者提供了新的靶向治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","LU0306807586.USD","IE0002270589.USD","IE000M9KFDE8.USD","LU0225284248.USD","LU0234572021.USD","BK4599","LU1883839398.USD","BK4007","BK4588","BK4585","IE00B19Z3B42.SGD","SG9999001176.USD","LU1023059063.AUD","LU0289739699.SGD","IE00BLSP4239.USD","LU1894683264.USD","LU0058720904.USD","LU1057294990.SGD","SG9999002224.SGD","SG9999011175.SGD","BK4592","SG9999013999.USD","LU0306806265.USD","LU0456855351.SGD","BK4533","LU1894683348.USD","LU0985481810.HKD","LU0170899867.USD","LU0225771236.USD","PFE","BK4550","SG9999003800.SGD","IE00B19Z3581.USD","SG9999001176.SGD","IE00BBT3K403.USD","LU0122379950.USD","LU0321505439.SGD","IE00BLSP4452.SGD","SGXZ57979304.SGD","BK4568","LU1066053197.SGD","LU0868494617.USD","SG9999002232.USD","BK4581","LU1066051498.USD","LU0321505868.SGD"],"gpt_icon":0},{"id":"2613760723","title":"中國減肥藥市場增加新跨國巨頭玩家，輝瑞也要加入「價格戰」？","url":"https://stock-news.laohu8.com/highlight/detail?id=2613760723","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613760723?lang=zh_tw&edition=fundamental","pubTime":"2026-02-24 15:23","pubTimestamp":1771917820,"startTime":"0","endTime":"0","summary":"继诺和诺德、礼来之后，中国的减肥药市场要添加新的跨国巨头玩家了。2月24日，先为达生物宣布与辉瑞中国达成商业化战略合作协议。根据协议，辉瑞将获得先为达生物新一代偏向型GLP-1受体激动剂埃诺格鲁肽注射液（埃诺格鲁肽）在中国大陆的独家商业化权益；同时先为达生物为许可产品的药品上市许可持有人，负责许可产品的研发、注册、生产及供应。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202602243652667436.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202602243652667436.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["SG9999002232.USD","SG9999001176.USD","IE00BLSP4452.SGD","LU0456855351.SGD","SG9999001176.SGD","LU0289739699.SGD","IE00BBT3K403.USD","LU1066053197.SGD","LU1894683264.USD","LU1894683348.USD","LU0306807586.USD","LU0058720904.USD","BK4533","PFE","LU0122379950.USD","BK4581","LU0170899867.USD","BK4599","LU0321505868.SGD","LU1066051498.USD","LU1023059063.AUD","LU0985481810.HKD","LU0868494617.USD","SG9999002224.SGD","LU0225284248.USD","SG9999013999.USD","LU0321505439.SGD","LU0225771236.USD","SG9999011175.SGD","BK4568","SG9999003800.SGD","BK4588","BK4592","BK4550","LU1057294990.SGD","LU0234572021.USD","LU0306806265.USD","BK4534","IE0002270589.USD","BK4585","BK4007","LU1883839398.USD","IE000M9KFDE8.USD","SGXZ57979304.SGD","IE00B19Z3B42.SGD","IE00B19Z3581.USD","IE00BLSP4239.USD"],"gpt_icon":1},{"id":"2613731768","title":"輝瑞與 Sciwind Biosciences 達成糖尿病藥物交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2613731768","media":"路透中文","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613731768?lang=zh_tw&edition=fundamental","pubTime":"2026-02-24 11:24","pubTimestamp":1771903485,"startTime":"0","endTime":"0","summary":"路透上海2月24日 - 辉瑞PFE.N周二表示，已与Sciwind Biosciences公司签订了一项2型糖尿病治疗药物ecnoglutide的许可协议，如果达到阶段性目标，辉瑞将支付高达4.95亿美元的费用。根据与辉瑞公司的协议，Sciwind 公司有资格获得一笔金额未公开的预付费，以及与监管和销售相关的里程碑相关的额外付款。该协议涉及ecnoglutide在中国大陆的商业化。与诺和诺德的Ozempic、礼来的Mounjaro和innogen的efsubaglutide alfa不同，ecnoglutide将不会被纳入中国2型糖尿病治疗的国家医疗保险计划。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nL4T3ZK0BE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109394709.USD","IE00BJJMRZ35.SGD","LU0198837287.USD","LU1057294990.SGD","IE00BKPKM429.USD","IE00BN29S564.USD","IE00BJLML261.HKD","LU0158827781.USD","LU0354030511.USD","LU1868836757.USD","LU2023250504.SGD","IE0002141913.USD","LU0170899867.USD","BK4581","IE00B1BXHZ80.USD","IE00BWXC8680.SGD","LU1988902786.USD","LU2168564149.EUR","LU2324357040.USD","LU2357305700.SGD","SG9999015986.USD","BK4516","LU0234572021.USD","LU2168564222.USD","BK4568","LU0868494617.USD","LU2265009873.SGD","LU1974910355.USD","91078","LU2756315664.SGD","IE00BJT1NW94.SGD","BK1589","LU0354030438.USD","LU2237443978.SGD","LU1983299246.USD","LU0708995401.HKD","LU2097828557.USD","SGXZ81514606.USD","BK4599","IE00BKDWB100.SGD","LU0502904849.HKD","LU0385154629.USD","LU0096364046.USD","LU2089284900.SGD","LU2462157665.USD","LU0455707207.USD","LU2471134796.USD","LU2213496289.HKD","SGXZ99366536.SGD","LU1035775433.USD","LU2089283258.USD","LU0058720904.USD","BK1583","LU2237443382.USD","LU0106261372.USD","LU0061475181.USD","LU1291159041.SGD","LU2237443465.HKD","ELIL","LU1323610961.USD","LU1868836914.USD","LU0289739699.SGD","LU1127390331.HKD","SG9999001176.USD","LU0882574055.USD","LU0079474960.USD","LU1366192091.USD","IE000M9KFDE8.USD","IE0001KFT4U8.USD","LU2063271972.USD","GB00BDT5M118.USD","LU1061106388.HKD","LU2361045086.USD","BK4588","LU0238689110.USD","LU1551013425.SGD","LU0256863811.USD","LU0640476718.USD","LLII","LU0109391861.USD","HK0000165453.HKD","LU2237443622.USD","LU1066053197.SGD","LU0820561818.USD","LU1868837300.USD","LU0466842654.USD","LU1814569148.SGD","LU1064131342.USD","LU2471134523.USD","SG9999011175.SGD","LU1069344957.HKD","SG9999002232.USD","LU2491050154.USD","IE00BLSP4452.SGD","LU2237438978.USD","LU0823416689.USD","LU0266013472.USD","LU2097828714.EUR","LU0210536198.USD","LU2108987350.USD","IE00BJJMRY28.SGD","LU0203201768.USD","LU2112291526.USD","LU0683600562.USD","LU0820562030.AUD","LU2264538146.SGD","LU1969619763.USD","BK4534","LU0122379950.USD","LU0203202063.USD","LU1894683348.USD","LU2552382058.USD","LU0417517546.SGD","LU1868837136.USD","BK4550","LU2242644610.SGD","LU2471134952.CNY","LU2023250330.USD","LU2237443895.HKD","LU0471298694.HKD","LU1720051108.HKD","LU1629891620.HKD","LU2746668461.USD","LU2111349929.HKD","LU0943347566.SGD","LU1868836591.USD","LU1720051017.SGD","IE0002270589.USD","LU1989771016.USD","LU0823434740.USD","LU0094547139.USD","LU0316494557.USD","LU1093756325.SGD","LU0306807586.USD","LU2468319806.SGD","LU0786609619.USD","LU2237443549.SGD","LU2552382132.HKD","LU1093756168.USD","LU1280957306.USD","LU1623119135.USD","LU1917777945.USD","IE00B1XK9C88.USD","LU0321505439.SGD","LU0689472784.USD","LU0256863902.USD","LU1883839398.USD","LU2361044949.HKD","IE00BFSS7M15.SGD","LU2488822045.USD","IE00BFSS8Q28.SGD","LU0320765992.SGD","LU2361044865.SGD","IE00B7KXQ091.USD","LU2456880835.USD","SG9999015945.SGD","IE00B19Z3581.USD","PFE","SG9999015978.USD","LLYX","LU1548497426.USD","SGXZ31699556.SGD","SG9999013999.USD","IE00B2B36J28.USD","IE0009355771.USD","LU2360106947.USD","SG9999014880.SGD","LU0353189763.USD","LU0823434583.USD","SGXZ57979304.SGD","SG9999002224.SGD","LU0964807845.USD","IE00B4R5TH58.HKD","IE00B19Z3B42.SGD","BK4592","IE00BBT3K403.USD","LU2236285917.USD","LU2328871848.SGD","LU2756315318.SGD","LU2417539215.USD","LU2896262040.SGD","SG9999018865.SGD","IE0005OL40V9.USD","IE0004445015.USD","LU0353189680.USD","LU0114720955.EUR","SG9999018857.SGD","SG9999014906.USD","SGXZ51526630.SGD","LU2089984988.USD","LU1145028129.USD","LU2471134879.HKD","LU0432979614.USD","IE00BJJMRX11.SGD","LU1804176565.USD","LU2168564065.EUR","BK4533","IE00BK4W5L77.USD","LU2087625088.SGD","SG9999014898.SGD","LU0471298777.SGD","LU0889565916.HKD","LU0323591593.USD","LU1232071149.USD","LU2097828474.EUR","LU2168564495.EUR","SG9999001176.SGD","LU2168563687.JPY","LU2552382215.SGD","LU0225283273.USD","LU0456855351.SGD","LU2097828631.EUR","ELIS","LU0225284248.USD","LU0672654240.SGD","LU1267930730.SGD","LU1066051498.USD","LU0820561909.HKD","LU2491050071.SGD","BK1161","LU0882574139.USD","LLYZ","LU1551013342.USD","LU2097828805.USD","SG9999015952.SGD","IE00BK4W5M84.HKD","LU2491049909.HKD","IE00B775H168.HKD","LU2211815571.USD","LU0306806265.USD","IE00BLSP4239.USD","BK4585","LU0787776722.HKD","LU1023059063.AUD","IE00BFTCPJ56.SGD","LU0985481810.HKD","LU0321505868.SGD","LU2023251221.USD","IE0004445239.USD","LU0225771236.USD","LU0320765059.SGD","IE00B4JS1V06.HKD","LU2746668974.SGD","LU2602419157.SGD","LU0158827948.USD","LU2106854487.HKD","LU2271345857.HKD","BK4007","LU0006306889.USD","LU0097036916.USD","LU2028103732.USD","LU2750360641.GBP","SG9999003800.SGD","LU1712237335.SGD","SG9999014914.USD","LU2461242641.AUD","LU2750360997.AUD","SG9999017495.SGD","LU1894683264.USD"],"gpt_icon":1},{"id":"2613897750","title":"先為達生物攜手輝瑞中國，達成埃諾格魯肽商業化戰略合作協議","url":"https://stock-news.laohu8.com/highlight/detail?id=2613897750","media":"市场资讯","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613897750?lang=zh_tw&edition=fundamental","pubTime":"2026-02-24 10:23","pubTimestamp":1771899780,"startTime":"0","endTime":"0","summary":"2月24日消息，杭州先为达生物科技股份有限公司与辉瑞中国今日宣布，双方就新一代偏向型GLP-1受体激动剂埃诺格鲁肽注射液 达成商业化战略合作协议。先为达生物将有权获得辉瑞支付的最高可达4.95亿美元的付款总额，包括首付款、注册及销售里程碑付款。　　埃诺格鲁肽是由先为达生物自主研发的新一代cAMP偏向型GLP-1受体激动剂，将为2型糖尿病及长期体重管理相关患者提供更为精准的治疗方案。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-02-24/doc-inhnwrqu6119933.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU1894683348.USD","LU0058720904.USD","LU0321505439.SGD","BK4585","LU0170899867.USD","BK4581","LU1023059063.AUD","LU0306806265.USD","BK4007","IE00BLSP4239.USD","SG9999001176.USD","PFE","LU0985481810.HKD","BK4599","LU1066053197.SGD","LU0456855351.SGD","IE00B19Z3B42.SGD","LU0321505868.SGD","SG9999011175.SGD","SGXZ57979304.SGD","91078","IE00BBT3K403.USD","IE00BLSP4452.SGD","SG9999001176.SGD","LU0234572021.USD","BK4533","IE000M9KFDE8.USD","LU1066051498.USD","SG9999003800.SGD","SG9999013999.USD","LU0225284248.USD","BK4568","BK4534","BK4588","LU0306807586.USD","LU1883839398.USD","SG9999002232.USD","BK4550","SG9999002224.SGD","LU0122379950.USD","LU0289739699.SGD","LU1057294990.SGD","LU0225771236.USD","IE00B19Z3581.USD","LU1894683264.USD","IE0002270589.USD","LU0868494617.USD","BK4592"],"gpt_icon":1},{"id":"2613527777","title":"BRIEF-中國先為達生物將向輝瑞收取至多4.95億美元，輝瑞獲其減肥藥在中國大陸的獨家商業化權益","url":"https://stock-news.laohu8.com/highlight/detail?id=2613527777","media":"路透中文","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613527777?lang=zh_tw&edition=fundamental","pubTime":"2026-02-24 09:56","pubTimestamp":1771898177,"startTime":"0","endTime":"0","summary":"BRIEF-中国先为达生物将向辉瑞收取至多4.95亿美元，辉瑞获其减肥药在中国大陆的独家商业化权益路透2月24日 - 中国生物科技公司先为达生物:中国生物科技公司先为达生物：将降糖减重药埃诺格鲁肽注射液在中国大陆的独家商业化权益授予辉瑞PFE.N先为达生物：将有权获得辉瑞支付的最高可达4.95亿美元的付款总额，包括首付款、注册及销售里程碑付款浏览公告详情，请点击此处 (发稿 徐凯文) ((Kaiwen.Xu@thomsonreuters.com;))","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nL4T3ZK06S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","BK4585","LU1894683264.USD","IE00B19Z3581.USD","LU0321505868.SGD","LU0225771236.USD","IE000M9KFDE8.USD","BK4007","BK4592","LU0234572021.USD","IE00B19Z3B42.SGD","BK4550","LU1057294990.SGD","91078","IE0002270589.USD","IE00BBT3K403.USD","BK4581","LU0868494617.USD","BK4599","SG9999011175.SGD","LU1883839398.USD","PFE","BK4588","SG9999001176.USD","LU0058720904.USD","LU0321505439.SGD","BK4568","LU0225284248.USD","BK4533","LU0456855351.SGD","LU1066051498.USD","IE00BLSP4452.SGD","LU1894683348.USD","LU0170899867.USD","LU0306807586.USD","SG9999003800.SGD","SG9999002232.USD","LU1023059063.AUD","LU0306806265.USD","SG9999001176.SGD","SGXZ57979304.SGD","SG9999002224.SGD","LU0289739699.SGD","LU0985481810.HKD","LU1066053197.SGD","SG9999013999.USD","IE00BLSP4239.USD","LU0122379950.USD"],"gpt_icon":0},{"id":"1110833815","title":"杭州Sciwind生物與輝瑞中國就新一代Ecnoglutide注射劑商業化達成戰略合作協議","url":"https://stock-news.laohu8.com/highlight/detail?id=1110833815","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110833815?lang=zh_tw&edition=fundamental","pubTime":"2026-02-24 09:30","pubTimestamp":1771896617,"startTime":"0","endTime":"0","summary":"杭州Sciwind生物科技公司与辉瑞中国已正式签署战略合作协议，共同推进新一代Ecnoglutide注射剂的商业化进程。此次合作旨在整合双方在研发与市场渠道方面的优势，加速该创新药物在中国市场的应用与推广。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999002224.SGD","LU1066051498.USD","02252","IE00BLSP4239.USD","SG9999002232.USD","SGXZ57979304.SGD","LU0321505439.SGD","LU1883839398.USD","SG9999001176.SGD","BK4585","BK4581","LU0985481810.HKD","LU1894683348.USD","IE00BBT3K403.USD","IE0002270589.USD","IE00B19Z3B42.SGD","LU0170899867.USD","LU0225284248.USD","IE00B19Z3581.USD","BK4599","LU1894683264.USD","BK4592","SG9999011175.SGD","LU0058720904.USD","LU1066053197.SGD","LU0456855351.SGD","BK4007","BK4534","LU0225771236.USD","LU1023059063.AUD","PFE","LU1057294990.SGD","LU0306806265.USD","LU0289739699.SGD","LU0306807586.USD","BK4533","BK4588","BK4550","IE000M9KFDE8.USD","LU0234572021.USD","BK4568","LU0868494617.USD","SG9999003800.SGD","SG9999013999.USD","LU0321505868.SGD","IE00BLSP4452.SGD","SG9999001176.USD","LU0122379950.USD"],"gpt_icon":0},{"id":"2613148209","title":"2025年全球暢銷藥TOP50來了","url":"https://stock-news.laohu8.com/highlight/detail?id=2613148209","media":"赛柏蓝","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613148209?lang=zh_tw&edition=fundamental","pubTime":"2026-02-22 18:24","pubTimestamp":1771755896,"startTime":"0","endTime":"0","summary":"作者 | 草履虫编辑 | 晓琳随着礼来、诺和诺德与默沙东相继发布2025年完整财报，2025全球畅销药TOP50新鲜出炉（表1）。此后，替尔泊肽的优势持续扩大，最终在2025年Q4完成绝杀，以全年365亿美元的销售额险胜司美格鲁肽。2025年12月，该复方已在美国申报上市。据Fierce Biotech数据，2025年前三季度全球生物制药领域累计裁员190起，已接近2024年全年总量。从数据来看，2025年共有13款创新药跨过百亿美元门槛。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022218302297a6a9dd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022218302297a6a9dd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0965509010.AUD","LU1074936037.SGD","LU0882574055.USD","LU2023250504.SGD","LU2505996509.AUD","LU0912757837.SGD","LU1974910355.USD","LU1057294990.SGD","LU1917777945.USD","BK4007","LU0234570918.USD","LU1032466523.USD","LU0265550359.USD","BK4550","PFE","IE0034235303.USD","BK4533","BK4559","BK4581","IE00B3PB1722.GBP","LU2471134952.CNY","SG9999013999.USD","LU0122379950.USD","LLY","SG9999011175.SGD","LU0456855351.SGD","LU0225771236.USD","LU0345770308.USD","LU0070217475.USD","LU0234572021.USD","LU1162221912.USD","IE000M9KFDE8.USD","LU0154236417.USD","LU0965509101.SGD","BK4532","IE00B19Z3581.USD","LU1989772840.SGD","LU0170899867.USD","LU2125154935.USD","LU0130517989.USD","LU2360032135.SGD","BK4585","LU1699723380.USD","LU0868494617.USD","LU1261432733.SGD","LU0321505868.SGD","LU1037948541.HKD","LU1093756325.SGD","LU1066051498.USD","IE00B1BXHZ80.USD","LU0225284248.USD","LU0861579265.USD","LU1061106388.HKD","LU2430703178.SGD","LU0114720955.EUR","LU0070302665.USD","LU2133065610.SGD","LU0985320562.USD","IE0001KFT4U8.USD","IE00BBT3K403.USD","BMY","LU1023059063.AUD","BK4599","IE00BSNM7G36.USD","IE00BVYPNW00.USD","LU0320765646.SGD","LU1732799900.SGD","LU0640476718.USD","LU1571399168.USD","LU1244550494.USD","LU0208291251.USD","SG9999001176.USD","BK4504","BK4588","BK4516","LU0124676726.USD","LU0985481810.HKD","LU1280957306.USD","LU1221951046.USD","LU2468319806.SGD","LU1291159041.SGD","IE0002141913.USD","LU2106854487.HKD","LU1066051225.USD","LU1066051811.HKD","LU1496350502.SGD","LU0203345920.USD","IE00BKVL7J92.USD","LU0098860793.USD","SG9999015341.SGD","LU0006306889.USD","SGXZ57979304.SGD","IE00B19Z3B42.SGD","LU0266013472.USD","SG9999002224.SGD","LU1929549753.HKD","LU2089984988.USD","LU2361045086.USD","SG9999014575.USD","IE00BLSP4452.SGD","LU2471134879.HKD","IE00B42XCP33.USD","LU1894683348.USD","LU2023250843.SGD","LU0345769631.USD","LU2430703251.USD","SG9999015358.SGD","LU2461242641.AUD","LU1934455277.USD","LU0289739699.SGD","LU2430703095.HKD","IE00BFTCPJ56.SGD","IE00BN8TJ469.HKD","LU0965509283.SGD","LU1883839398.USD","LU1983299246.USD","LU0683600562.USD","LU1116320901.HKD","LU0130102774.USD","SG9999014559.SGD","LU0889566641.SGD","LU1267930813.SGD","LU2361044865.SGD","LU2505996681.GBP","IE00B3T34201.USD","LU1066053197.SGD","LU0306807586.USD","LU0648001328.SGD","LU1914381329.SGD","LU1894683264.USD","LU2361044949.HKD","LU1674673691.USD","LU0058720904.USD","LU1201861249.SGD","LU1244550577.SGD","LU1430594728.SGD","LU1221951129.SGD","LU1585245621.USD","LU0265550946.USD","SG9999003800.SGD","IE00B2B36J28.USD","LU1244550221.USD","LU1506573853.SGD","LU2347655156.SGD","SG9999014542.SGD","IE00BVYPNV92.GBP","LU1718418525.SGD","LU1116320737.USD","LU2112291526.USD","BK4592","LU2125154778.USD","LU1989771016.USD","LU1037948897.HKD","LU2471134796.USD","LU1941712348.USD","LU2129689514.USD","LU1069347547.HKD","LU2471134523.USD","IE0002270589.USD","LU0787776722.HKD","LU1059921491.USD","LU0238689110.USD","LU0211331839.USD","LU1778281490.HKD","BK4568","IE00BLSP4239.USD","LU1935042991.SGD","IE00BJJMRZ35.SGD","LU0477156953.USD","LU1732800096.USD","LU0466842654.USD","LU0106261372.USD","LU0795875169.SGD","LU1196500208.SGD","LU1934455194.USD","LU2324357040.USD","NVO","LU1032955483.USD","NVOH","LU0689626769.HKD","LU0345770993.USD","IE00BZ1G4Q59.USD","LU0980610538.SGD","IE00B4R5TH58.HKD","LU1093756168.USD","LU1941712264.USD","IE00B7SZLL34.SGD","LU0321505439.SGD","LU1989772923.USD","IE00BJT1NW94.SGD","LU2129689605.HKD","LU2602419157.SGD","IE0009355771.USD","LU2592432038.USD","SG9999001176.SGD","NVOX","LU0320765489.SGD","LU0795875086.SGD","IE00BFXG1179.USD","LU0345769128.USD","BK4534","IE00BGHQF631.EUR","LU1035773651.USD","LU0965508806.USD","LU1674673428.USD","LU2750360641.GBP","SG9999001440.SGD","SG9999002232.USD","LU0203347892.USD","LU1934455863.HKD","LU0432979614.USD","LU0306806265.USD","LU2750360997.AUD","SG9999014567.USD","IE00BDGV0183.EUR","LU0792757196.USD","LU2129689431.USD","MRK"],"gpt_icon":1},{"id":"2611819982","title":"2025年藥企營收TOP10","url":"https://stock-news.laohu8.com/highlight/detail?id=2611819982","media":"药智网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611819982?lang=zh_tw&edition=fundamental","pubTime":"2026-02-13 15:44","pubTimestamp":1770968675,"startTime":"0","endTime":"0","summary":"2025年，药企营收TOP10名单中，大部分公司实现了业绩增长。表1 2025年全球制药企业营收TOP10概览资料来源：根据公开资料整理01礼来狂飙礼来无疑是本年度最耀眼的主角，其连续三年占据行业增幅榜首。阿斯利康2025年营收587亿美元，同比增长8%。其2025年总收入为626亿美元，较2024年的636亿美元下降2%。2026年，辉瑞预计收入将继续下滑至595亿至625亿美元。2026年，默沙东预计销售额预计在655亿美元至670亿美元之间，保持微增。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260213154719a49fc62c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260213154719a49fc62c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1934455863.HKD","PFE","LU0072461881.USD","LU0868494617.USD","SG9999002232.USD","LU1037948541.HKD","LU1116320737.USD","BK4585","LU0289739699.SGD","LU0965509101.SGD","LU1894683348.USD","LU2106854487.HKD","IE00B19Z3581.USD","LU1430594728.SGD","LU2089984988.USD","SG9999001440.SGD","LU0211331839.USD","BK4533","IE0009355771.USD","LU1989772923.USD","SG9999014559.SGD","SG9999001176.USD","IE00BN8TJ469.HKD","LU1291159041.SGD","LU1974910355.USD","ABBV","LU0320765646.SGD","IE00B1BXHZ80.USD","BK4007","LU1941712264.USD","LU0965508806.USD","LU2125154935.USD","IE00BLSP4452.SGD","SG9999003800.SGD","SG9999014567.USD","SG9999014575.USD","IE00BJJMRZ35.SGD","LU2468319806.SGD","LU2023250843.SGD","LU1894683264.USD","LU0098860793.USD","LU1989772840.SGD","AZN","IE00BJT1NW94.SGD","LU0965509283.SGD","LU1934455194.USD","LU0266013472.USD","LU0985320562.USD","LU0106261372.USD","SG9999015341.SGD","LU1585245621.USD","LU1917777945.USD","LU1066051498.USD","LU0306807586.USD","BK4550","LU2360032135.SGD","LU2461242641.AUD","LU2361044865.SGD","LU1037948897.HKD","LU1069347547.HKD","SG9999013999.USD","LU0130517989.USD","LU0861579265.USD","LU2361044949.HKD","LU1201861249.SGD","LU1941712348.USD","SNY","IE00B19Z3B42.SGD","BK4599","LU0130102774.USD","LU1116320901.HKD","LU0070302665.USD","LU0320765489.SGD","LLY","LU1066051811.HKD","LU0321505439.SGD","MRK","LU0965509010.AUD","BK4201","IE00BBT3K403.USD","LU0648001328.SGD","BK4581","IE000M9KFDE8.USD","IE00B2B36J28.USD","LU1057294990.SGD","LU0477156953.USD","LU1829250122.USD","IE00BSNM7G36.USD","IE0002141913.USD","LU1023059063.AUD","SG9999015358.SGD","LU2125154778.USD","LU1066053197.SGD","LU2361045086.USD","LU0306806265.USD","BK4592","LU0203345920.USD","LU0225771236.USD","LU1093756168.USD","LU0265550946.USD","BK4559","IE0002270589.USD","LU0208291251.USD","LU0238689110.USD","SGXZ57979304.SGD","RHHBY","LU0432979614.USD","LU1066051225.USD","IE00BLSP4239.USD","LU0225284248.USD","BMY","LU0980610538.SGD","LU1093756325.SGD","JNJ","LU1035773651.USD","LU0985481810.HKD","LU1571399168.USD","BK4534","IE00B4R5TH58.HKD","LU1162221912.USD","LU1989771016.USD","SG9999001176.SGD","LU0162691827.USD","LU2023250504.SGD","LU0265550359.USD","LU1934455277.USD","LU0006306889.USD","SG9999002224.SGD","LU0170899867.USD","LU1061106388.HKD","LU0203347892.USD","SG9999011175.SGD","SG9999014542.SGD","BK4568","IE00BFTCPJ56.SGD","LU0321505868.SGD","LU0058720904.USD","LU0122379950.USD","LU0456855351.SGD","LU2112291526.USD","LU1983299246.USD","BK4588","BK4516","LU2324357040.USD","LU1929549753.HKD","LU0234572021.USD","LU1883839398.USD","LU1699723380.USD"],"gpt_icon":1},{"id":"2610692040","title":"標普500【8】為什麼「新冠剋星」，只能是輝瑞？（9）","url":"https://stock-news.laohu8.com/highlight/detail?id=2610692040","media":"弄鬼妆幺","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610692040?lang=zh_tw&edition=fundamental","pubTime":"2026-02-12 22:53","pubTimestamp":1770908019,"startTime":"0","endTime":"0","summary":"我正在做一件笨事：按成立顺序，写完标普500的企业。然而，2016年辉瑞与艾尔建高达1600亿美元合并案的流产，具有深远的历史分水岭意义。IQVIA研究所在《全球药物使用趋势》报告中指出，发达市场的特药支出占比已超过50%，这验证了辉瑞向特药转型的行业必然性。03新冠克星，为什么是辉瑞？2020年的新冠疫情意外地成为了辉瑞解决主要矛盾——资本与科学冲突——的历史契机。(辉瑞推出mRNA疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260212230414a6f3ea21&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260212230414a6f3ea21&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","IE00BBT3K403.USD","LU0234572021.USD","LU0985481810.HKD","UPRO","SG9999003800.SGD","IVV","BK4592","SPXU","PFE","LU1023059063.AUD","LU1894683264.USD","BK4559","OEF","SPYM","SPXS","SVXY","IE00B19Z3581.USD","BK4550","LU0225284248.USD","BK4585","BMAY","BK4534","IE0002270589.USD","GPIX","LU0170899867.USD","BK4533","VYLD","SPXL","SPDN","LU1066051498.USD","VIXM","SG9999002224.SGD","LU0868494617.USD","VIXmain","VXZ","LU1057294990.SGD","SGXZ57979304.SGD","IVOO","SG9999002232.USD","IE000M9KFDE8.USD","BK4568","SPY","SG9999001176.SGD","LU0321505439.SGD","LU1894683348.USD","BK4599","VIXY","BK4581","SH","XDTE","ESmain","IE00BLSP4452.SGD","VTI","LU0225771236.USD","LU0122379950.USD","UVXY","TVIXF","SG9999013999.USD","SDS","SPLV","VVIX","USMV","VXMmain","LU0306806265.USD","SG9999001176.USD","LU0321505868.SGD","VXX","LU0456855351.SGD","OEX","IVW","LU0289739699.SGD","BK4588","SVIX","MESmain","LU0058720904.USD","SPYV","HIBL","LU1883839398.USD","SSO","VOOV","SVOL","BK4504","LU1066053197.SGD","IE00B19Z3B42.SGD","LU0306807586.USD","IE00BLSP4239.USD","SG9999011175.SGD"],"gpt_icon":1},{"id":"2610675864","title":"輝瑞將從美國證券交易委員會起訴史蒂文-科恩對沖基金案中獲賠 2900 萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2610675864","media":"路透中文","labels":["shareholding","policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610675864?lang=zh_tw&edition=fundamental","pubTime":"2026-02-11 04:19","pubTimestamp":1770754798,"startTime":"0","endTime":"0","summary":"辉瑞将从美国证券交易委员会起诉史蒂文-科恩对冲基金案中获赔 2900 万美元和解将终止辉瑞与内幕交易案有关的上诉SAC Capital 与美国证券交易委员会和解后剩余的资金需要法院批准美国证券交易委员会未立即发表评论Jonathan Stempel. 马雷罗同意美国证券交易委员会的意见，认为 7,520 万美元应全部归美国财政部所有。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260210:nL4S3Z62DM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0456855351.SGD","SG9999002232.USD","IE000M9KFDE8.USD","IE00BBT3K403.USD","LU0225771236.USD","BK4568","IE00BLSP4239.USD","LU0225284248.USD","SG9999013999.USD","LU1066051498.USD","SG9999003800.SGD","SG9999011175.SGD","LU0321505868.SGD","LU1023059063.AUD","SG9999002224.SGD","SGXZ57979304.SGD","BK4588","BK4581","LU0306806265.USD","BK4007","LU0058720904.USD","LU1894683348.USD","IE0002270589.USD","IE00B19Z3581.USD","LU0985481810.HKD","LU0289739699.SGD","LU1057294990.SGD","LU0321505439.SGD","SG9999001176.USD","LU1066053197.SGD","IE00BLSP4452.SGD","BK4599","LU0868494617.USD","SG9999001176.SGD","BK4592","LU0122379950.USD","PFE","BK4585","LU0234572021.USD","IE00B19Z3B42.SGD","BK4550","LU1883839398.USD","BK4533","LU0306807586.USD","LU1894683264.USD","LU0170899867.USD","BK4534"],"gpt_icon":0},{"id":"1182484790","title":"輝瑞第四財季淨利潤達14.2億盧比","url":"https://stock-news.laohu8.com/highlight/detail?id=1182484790","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182484790?lang=zh_tw&edition=fundamental","pubTime":"2026-02-09 22:49","pubTimestamp":1770648556,"startTime":"0","endTime":"0","summary":"辉瑞有限公司最新财报显示，公司在第四财季实现净利润14.2亿卢比。同期，公司营业收入为64.5亿卢比。财报数据反映出企业当季的盈利能力和运营表现。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BLSP4239.USD","BK4007","LU0225284248.USD","PFE","SG9999003800.SGD","IE00BLSP4452.SGD","IE00B19Z3B42.SGD","BK4599","LU1894683264.USD","LU0985481810.HKD","LU0868494617.USD","SG9999002232.USD","BK4534","LU0321505439.SGD","SG9999001176.SGD","BK4585","IE00BBT3K403.USD","LU0289739699.SGD","BK4581","LU1894683348.USD","SG9999002224.SGD","IE000M9KFDE8.USD","LU0170899867.USD","LU1057294990.SGD","IE00B19Z3581.USD","LU0306807586.USD","LU1066051498.USD","BK4550","SG9999011175.SGD","LU1023059063.AUD","BK4568","LU1066053197.SGD","LU0321505868.SGD","BK4533","LU0306806265.USD","LU0058720904.USD","BK4592","LU0225771236.USD","LU0122379950.USD","SG9999013999.USD","SG9999001176.USD","LU0456855351.SGD","BK4588","IE0002270589.USD","LU0234572021.USD","LU1883839398.USD","SGXZ57979304.SGD"],"gpt_icon":0},{"id":"2610076835","title":"紅杉中國抄底拜覆樂，指派輝瑞金肖東復興老牌抗生素？","url":"https://stock-news.laohu8.com/highlight/detail?id=2610076835","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610076835?lang=zh_tw&edition=fundamental","pubTime":"2026-02-09 11:07","pubTimestamp":1770606471,"startTime":"0","endTime":"0","summary":"根据协议，杉泽生物拿下了拜复乐在全球范围内的药品注册证、知识产权及业务合同等核心资产使其成为一家由投资机构100%控股的全球性医药资产。红杉的动作迅速且精准，为这个新平台请来了一位重量级舵手金肖东。被誉为“呼吸科神药”的拜复乐，能否在金肖东的手中迎来“第二春”？在中国市场，尽管拜复乐依然占据领先地位，但市场份额正不断被国内仿制药企业蚕食。金肖东近30年的职业生涯完美契合了杉泽生物“双轮驱动”的战略需求。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1770126030476832572","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["LU0225284248.USD","SG9999002224.SGD","SG9999001176.USD","LU0225771236.USD","LU0058720904.USD","LU1894683264.USD","IE00BLSP4452.SGD","LU1023059063.AUD","LU0306807586.USD","LU0985481810.HKD","BK4599","BK4550","IE000M9KFDE8.USD","IE00BLSP4239.USD","LU1894683348.USD","PFE","LU1883839398.USD","LU1057294990.SGD","LU0289739699.SGD","BK4568","LU0122379950.USD","IE00B19Z3581.USD","LU0234572021.USD","SG9999002232.USD","BK4592","BK4588","BK4533","BK4007","LU0868494617.USD","BK4581","LU0170899867.USD","SG9999001176.SGD","SG9999003800.SGD","LU1066051498.USD","LU0321505868.SGD","IE00BBT3K403.USD","BK4534","SG9999013999.USD","IE0002270589.USD","LU0321505439.SGD","BAYRY","SGXZ57979304.SGD","IE00B19Z3B42.SGD","SG9999011175.SGD","BK4585","LU0456855351.SGD","LU0306806265.USD","LU1066053197.SGD"],"gpt_icon":0},{"id":"2609521049","title":"諾和諾德聯合減重療法臨床3期結果積極；輝瑞超長效GLP-1受體激動劑將啓動3期試驗…… | TIDES周報","url":"https://stock-news.laohu8.com/highlight/detail?id=2609521049","media":"药明康德","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609521049?lang=zh_tw&edition=fundamental","pubTime":"2026-02-08 07:31","pubTimestamp":1770507063,"startTime":"0","endTime":"0","summary":"CagriSema：公布3期临床试验数据诺和诺德公布全球REIMAGINE临床试验项目中REIMAGINE 2临床3期研究的主要结果。PF'3944是一款超长效、完全偏向性的GLP-1受体激动剂，是辉瑞通过近期收购Metsera所获得的管线，目前正被开发为每周单药治疗及每月治疗方案。截至第28周，PF'3944保持了与GLP-1 RA类药物一致的良好耐受性和有利的安全性特征。目前，MT1013正在中国开展针对该患者群体的3期临床研究，已入组超50%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260208073656a4896362&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260208073656a4896362&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0306806265.USD","LU0321505439.SGD","IE00BLSP4452.SGD","SG9999001176.SGD","BK4599","LU0225284248.USD","BK4592","IE000M9KFDE8.USD","BK4590","SG9999001176.USD","SG9999011175.SGD","BK4007","BK4532","LU0170899867.USD","IE00BZ1G4Q59.USD","LU0868494617.USD","PFE","IE00BKVL7J92.USD","SG9999002224.SGD","LU1057294990.SGD","LU0289739699.SGD","LU0985481810.HKD","SG9999013999.USD","LU1093756168.USD","LU1023059063.AUD","BK4144","BK4581","IE00BLSP4239.USD","LU0225771236.USD","SG9999003800.SGD","BK4534","BK4568","LU1066051498.USD","IE0002270589.USD","IE00B19Z3581.USD","LU1066053197.SGD","BK4585","LU1093756325.SGD","NVOH","NVO","LU0058720904.USD","IE00BBT3K403.USD","LU0456855351.SGD","BK4550","BK4533","LU0234572021.USD","LU0154236417.USD","SGXZ57979304.SGD","LU1894683264.USD","LU1894683348.USD","LU1883839398.USD","IE00B19Z3B42.SGD","SG9999002232.USD","BK4588","LU0306807586.USD","LU0122379950.USD","LU0321505868.SGD","NVOX"],"gpt_icon":0},{"id":"2609175845","title":"專家稱，TrumpRx 在推出減肥藥之外，影響力有限","url":"https://stock-news.laohu8.com/highlight/detail?id=2609175845","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609175845?lang=zh_tw&edition=fundamental","pubTime":"2026-02-07 07:15","pubTimestamp":1770419707,"startTime":"0","endTime":"0","summary":"专家称，TrumpRx 在推出减肥药之外，影响力有限生育药品也大幅打折推出之初，网站上只有五家制造商生产的药品TrumpRx 网站不直接销售药品Michael Erman. 路透2月6日 - 美国总统特朗普  的新处方药网站 TrumpRx.gov 主要关注的是政府为流行的 GLP-1 减肥药用户谈判达成的大幅折扣，专家表示，这限制了其为所有消费者节省的费用。\"对于美国的大多数人来说，如果他们需要的药物在他们的医保范围内，他们可能最好用医保支付药费，而不使用 TrumpRx。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260206:nL4T3Z229H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1057294990.SGD","LU1989771016.USD","IE00B775H168.HKD","BK4534","LU2237443549.SGD","LU2089984988.USD","LU0225284248.USD","LU1720051108.HKD","LU1064131342.USD","SG9999001176.USD","LU2236285917.USD","LU1035775433.USD","SG9999014914.USD","LU2112291526.USD","IE00B1BXHZ80.USD","BK4533","LU2746668974.SGD","LU2756315664.SGD","LU2265009873.SGD","BK4585","BK4581","LU2237443978.SGD","LU0320765059.SGD","IE0004445239.USD","IE00B1XK9C88.USD","LU1551013342.USD","LU2471134523.USD","SG9999017495.SGD","LU0708995401.HKD","LU0353189680.USD","SGXZ99366536.SGD","LU1868836757.USD","LU2896262040.SGD","LU0943347566.SGD","LU2089284900.SGD","LU2168564149.EUR","LU1868837300.USD","LU1061106388.HKD","LU1868836591.USD","LU2360106947.USD","IE00B4JS1V06.HKD","IE00B7KXQ091.USD","LU2461242641.AUD","LU1023059063.AUD","LU1366192091.USD","LU2237443895.HKD","IE00BJJMRX11.SGD","IE0002141913.USD","LU1093756168.USD","LU2471134796.USD","IE0004445015.USD","PFE","IE00BN29S564.USD","LU0321505439.SGD","LU0109394709.USD","LU2063271972.USD","IE000M9KFDE8.USD","IE00BBT3K403.USD","LU0985481810.HKD","LU1551013425.SGD","BK4568","LU0170899867.USD","LU2746668461.USD","LU0385154629.USD","IE0009355771.USD","LU2028103732.USD","LU1814569148.SGD","LU2168564065.EUR","LU2756315318.SGD","SG9999003800.SGD","SG9999015945.SGD","BK4599","LU2462157665.USD","SG9999018857.SGD","SGXZ31699556.SGD","IE00B2B36J28.USD","LU0354030511.USD","LU1868836914.USD","LU0471298777.SGD","LU0058720904.USD","LU0882574055.USD","LU1720051017.SGD","LU1883839398.USD","LU1988902786.USD","SG9999014880.SGD","LU0466842654.USD","SG9999002224.SGD","LU0225771236.USD","LU1804176565.USD","IE00BK4W5L77.USD","LU2237438978.USD","LU2023250330.USD","LU1894683264.USD","BK4592","LU2417539215.USD","LU0158827948.USD","LU0320765992.SGD","LU1712237335.SGD","LU2168564222.USD","LU0109391861.USD","LU1291159041.SGD","LU2456880835.USD","LU0266013472.USD","LU0823434583.USD","LU2237443382.USD","IE00BJJMRZ35.SGD","SG9999014898.SGD","LU2361044865.SGD","LU1917777945.USD","LU0640476718.USD","LU1548497426.USD","LU0432979614.USD","IE00BFTCPJ56.SGD","LLYZ","LU0238689110.USD","LU2211815571.USD","LU0471298694.HKD","LU1093756325.SGD","LU0353189763.USD","IE00B4R5TH58.HKD","LU0289739699.SGD","SGXZ81514606.USD","SG9999015978.USD","LU1069344957.HKD","LU0122379950.USD","LU1232071149.USD","LU2237443622.USD","LU1145028129.USD","LU2361045086.USD","LU2087625088.SGD","SG9999001176.SGD","LU0683600562.USD","LU0316494557.USD","LU0868494617.USD","LU0306806265.USD","LU2168563687.JPY","SGXZ57979304.SGD","LU0256863902.USD","LU0787776722.HKD","LU0820561818.USD","LU2168564495.EUR","SG9999015986.USD","LU0964807845.USD","LU0203202063.USD","LU2552382215.SGD","LU2213496289.HKD","LU2471134879.HKD","LU2324357040.USD","BK4516","LU1066053197.SGD","LU2361044949.HKD","LU0203201768.USD","IE00BK4W5M84.HKD","LU0820562030.AUD","SG9999013999.USD","LU2106854487.HKD","IE00BLSP4452.SGD","LU2750360641.GBP","LU0106261372.USD","IE0005OL40V9.USD","IE00BJLML261.HKD","LU1623119135.USD","LU0234572021.USD","LU0823416689.USD","LU2491050071.SGD","SG9999011175.SGD","LLYX","LU0321505868.SGD","LU2491049909.HKD","LU0006306889.USD","LU1974910355.USD","LU0079474960.USD","IE00BJT1NW94.SGD","ELIS","LU0889565916.HKD","LU2089283258.USD","IE00BFSS8Q28.SGD","LU2264538146.SGD","IE00BWXC8680.SGD","IE00B19Z3B42.SGD","IE0002270589.USD","BK4588","LU0456855351.SGD","LU0306807586.USD","LU0097036916.USD","LU0820561909.HKD","LU2111349929.HKD","LU2271345857.HKD","LU2471134952.CNY","LU0061475181.USD","SGXZ51526630.SGD","ELIL","LU2023251221.USD","LU0672654240.SGD","LU0198837287.USD","LU2468319806.SGD","IE00BLSP4239.USD","LU2750360997.AUD","LU2237443465.HKD","SG9999018865.SGD","LU0786609619.USD","LU1868837136.USD","LU1894683348.USD","LU0210536198.USD","IE00BFSS7M15.SGD","LU2602419157.SGD","LU0096364046.USD","LU1629891620.HKD","LU0323591593.USD","LU1983299246.USD","LU1280957306.USD","LU1267930730.SGD","IE00BJJMRY28.SGD","LU0158827781.USD","LU0354030438.USD","LU2552382058.USD","IE00BKPKM429.USD","GB00BDT5M118.USD","BK4007","LU2491050154.USD","LU0094547139.USD","BK4550","IE00B19Z3581.USD","LU0823434740.USD","LU0882574139.USD","LU2023250504.SGD","LU0225283273.USD","LU0417517546.SGD","LU1066051498.USD","LU2357305700.SGD","LU0114720955.EUR","IE00BKDWB100.SGD","SG9999015952.SGD","LU1127390331.HKD","LU0689472784.USD","LU1323610961.USD","SG9999014906.USD","LU2552382132.HKD","SG9999002232.USD","LU0256863811.USD","LU2108987350.USD"],"gpt_icon":1},{"id":"2609591202","title":"輝瑞抗感染創新藥獲批兒科適應證","url":"https://stock-news.laohu8.com/highlight/detail?id=2609591202","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609591202?lang=zh_tw&edition=fundamental","pubTime":"2026-02-06 22:20","pubTimestamp":1770387607,"startTime":"0","endTime":"0","summary":null,"market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4568","LU0985481810.HKD","SG9999002224.SGD","IE0002270589.USD","BK1574","BK4592","IE00B19Z3B42.SGD","LU1066051498.USD","PFE","SG9999002232.USD","BK4585","LU1066053197.SGD","SG9999013999.USD","LU0306807586.USD","LU0225771236.USD","BK4588","SG9999003800.SGD","BK4007","LU0225284248.USD","LU1894683348.USD","LU0321505439.SGD","LU1023059063.AUD","BK4550","LU0058720904.USD","LU0456855351.SGD","LU0122379950.USD","LU1894683264.USD","LU0170899867.USD","LU1057294990.SGD","IE00BLSP4452.SGD","SGXZ57979304.SGD","IE00BLSP4239.USD","BK4533","BK4581","SG9999001176.USD","IE00B19Z3581.USD","BK4534","SG9999011175.SGD","BK1161","LU0289739699.SGD","LU0868494617.USD","LU0306806265.USD","BK4599","IE000M9KFDE8.USD","LU0234572021.USD","LU0321505868.SGD","IE00BBT3K403.USD","LU1883839398.USD","SG9999001176.SGD"],"gpt_icon":0},{"id":"1119071271","title":"FDA授予Hympavzi®（Marstacimab）優先審評資格，用於治療存在重大醫療需求的兩類血友病A或B患者羣體","url":"https://stock-news.laohu8.com/highlight/detail?id=1119071271","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119071271?lang=zh_tw&edition=fundamental","pubTime":"2026-02-06 19:45","pubTimestamp":1770378357,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局（FDA）已授予Hympavzi®（Marstacimab）补充生物制剂许可申请（sBLA）优先审评资格。该药物旨在治疗存在重大医疗需求的两类血友病A或B患者群体。\n优先审评资格的授予，意味着FDA认为该疗法有潜力在安全性或有效性方面为患者提供显著改善。此举有望加速Hympavzi®的审批进程，为亟需新治疗选择的血友病患者带来希望。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0234572021.USD","BK4592","IE00B19Z3581.USD","LU0985481810.HKD","IE00BLSP4452.SGD","LU1066053197.SGD","LU0170899867.USD","LU0289739699.SGD","LU0456855351.SGD","BK4534","SG9999011175.SGD","IE0002270589.USD","IE000M9KFDE8.USD","SG9999002224.SGD","LU1894683264.USD","BK4007","LU0306806265.USD","SG9999013999.USD","LU1894683348.USD","IE00B19Z3B42.SGD","LU0122379950.USD","BK4585","SG9999001176.SGD","SG9999002232.USD","BK4588","PFE","LU0225284248.USD","BK4550","LU0058720904.USD","IE00BLSP4239.USD","LU1883839398.USD","SG9999003800.SGD","LU0321505439.SGD","IE00BBT3K403.USD","LU1066051498.USD","LU0868494617.USD","SG9999001176.USD","LU1023059063.AUD","LU1057294990.SGD","BK4533","LU0306807586.USD","LU0321505868.SGD","BK4568","SGXZ57979304.SGD","LU0225771236.USD","BK4599","BK4581"],"gpt_icon":0},{"id":"1191151847","title":"輝瑞推出優惠計劃：覆蓋女性健康、偏頭痛、關節炎及罕見病等30多個品牌","url":"https://stock-news.laohu8.com/highlight/detail?id=1191151847","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191151847?lang=zh_tw&edition=fundamental","pubTime":"2026-02-06 08:14","pubTimestamp":1770336852,"startTime":"0","endTime":"0","summary":"辉瑞公司近日宣布推出一项新的优惠计划，该计划涵盖超过30个品牌，涉及女性健康、偏头痛、关节炎、罕见疾病等多个治疗领域。通过这一计划，患者有望在购买相关药物时获得费用节省。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0002270589.USD","SG9999001176.USD","BK4568","SG9999002232.USD","BK4534","LU0868494617.USD","LU1057294990.SGD","LU1894683264.USD","LU0321505868.SGD","BK4599","LU0225284248.USD","PFE","SG9999001176.SGD","LU0122379950.USD","BK4588","IE00BLSP4452.SGD","SG9999013999.USD","LU0058720904.USD","IE00B19Z3581.USD","BK4533","LU0289739699.SGD","LU1023059063.AUD","BK4550","LU0321505439.SGD","IE00B19Z3B42.SGD","BK4585","SG9999011175.SGD","IE00BBT3K403.USD","SGXZ57979304.SGD","LU0170899867.USD","BK4007","LU1883839398.USD","LU1066053197.SGD","LU0985481810.HKD","BK4592","LU1894683348.USD","LU0234572021.USD","LU0306806265.USD","IE00BLSP4239.USD","SG9999002224.SGD","BK4581","SG9999003800.SGD","LU0306807586.USD","LU1066051498.USD","LU0456855351.SGD","IE000M9KFDE8.USD","LU0225771236.USD"],"gpt_icon":0},{"id":"2609373106","title":"減肥藥稱王！輝瑞百億美元入場要彎道超車？","url":"https://stock-news.laohu8.com/highlight/detail?id=2609373106","media":"新康界","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609373106?lang=zh_tw&edition=fundamental","pubTime":"2026-02-05 17:40","pubTimestamp":1770284428,"startTime":"0","endTime":"0","summary":"值得关注的是，2025年的减肥药市场从诺和诺德领跑转向礼来反超。第四季度单季表现尤为强劲，两款产品合计收入116.7亿美元，同比增长超110%。其中减重版Wegovy销售额125亿美元，36%的涨幅，对诺和诺德业绩贡献最高。辉瑞想要弯道超车？辉瑞2025年全年营收626亿美元。该药物是辉瑞2025年11月以约70亿美元收购Metsera获得的核心管线，旨在开发每月一次注射方案。但辉瑞却可以借此成功切入减肥赛道。辉瑞作为新入局者，月疗方案若成功，可能开辟新的细分市场。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260205174600a6d6a221&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260205174600a6d6a221&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BBT3K403.USD","SG9999003800.SGD","IE00BLSP4452.SGD","SGXZ57979304.SGD","SG9999002224.SGD","LU0868494617.USD","IE00BKVL7J92.USD","LU0289739699.SGD","LU1066051498.USD","LU0154236417.USD","IE00BLSP4239.USD","LU0225771236.USD","IE000M9KFDE8.USD","BK4550","PFE","LU1066053197.SGD","IE00B19Z3581.USD","LU1023059063.AUD","NVOH","NVOX","IE00B19Z3B42.SGD","IE00BZ1G4Q59.USD","LU0985481810.HKD","SG9999001176.SGD","LU1057294990.SGD","LU0122379950.USD","LU0306806265.USD","LU0225284248.USD","LU0456855351.SGD","LU0058720904.USD","LU0321505439.SGD","LU0306807586.USD","BK4568","LU1894683264.USD","LU1093756325.SGD","BK4599","LU1093756168.USD","LU0321505868.SGD","BK4007","BK4585","BK4534","LU1894683348.USD","BK4581","BK4588","SG9999001176.USD","BK4532","BK4592","LU1883839398.USD","SG9999013999.USD","SG9999002232.USD","IE0002270589.USD","LU0170899867.USD","SG9999011175.SGD","LU0234572021.USD","BK4533","NVO"],"gpt_icon":1}],"pageSize":20,"totalPage":20,"pageCount":1,"totalSize":398,"code":"91000000","status":"200"}]}}